Blepharochalasis

H7_BLEPHAROCHALASIS

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — H02.3 Hospital discharge: ICD-9 — 3743B Cause of death: ICD-10 — H02.3 Cause of death: ICD-9 — 3743B 2 out of 7 registries used, show all original rules.	13444
4. Check minimum number of events None	13444
5. Include endpoints None	13444
6. Filter based on genotype QC (FinnGen only)	13121

Control definitions (FinnGen only)

Control exclude: H7_LIDLACRIMALORBIT

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: H02
Name in latin: Dermatochalasis

NAME	H7_BLEPHAROCHALASIS
CONTROL_EXCLUDE	H7_LIDLACRIMALORBIT
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	H023
HD_ICD_9	3743B
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	H023
COD_ICD_9	3743B
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Blepharochalasis based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	66351	47232	18948
Only index persons	63111	45180	17931
Unadjusted period prevalence (%)
Whole population	1.11	1.35	0.53
Only index persons	1.38	1.66	0.68
Median age at first event (years)
Whole population	64.88	64.11	66.77
Only index persons	64.53	63.74	66.53

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	13121	9012	4109
Unadjusted period prevalence (%)	2.79	3.20	1.88
Median age at first event (years)	64.08	62.45	67.67

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
13444: Matched controls
134440

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

3743B

ICD-9 Finland

Other disorders of eyelids, Ptosis of eyelid[BLEPHAROCHALASIS ET DERMATOCHALASIS]

+∞

315.8

302

WX110

NOMESCO Finland

Infiltration anesthesia

2.1

308.4

9691

74262

H02.4

ICD-10 Finland

Ptosis of eyelid

126.9

307.7

2298

218

H02.0

ICD-10 Finland

Entropion and trichiasis of eyelid

151.4

307.7

524

H02.3

ICD-10 Finland

Blepharochalasis

22434.6

307.7

13183

302

CBB21

NOMESCO Finland

Correction of lax skin and resection of herniated fat in upper eyelid

935.8

307.7

875

CBB20

NOMESCO Finland

Correction of lax skin of eyelid and resection of herniated fat

438.4

307.7

1721

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

2.3

307.7

7321

46292

H04.10

ICD-10 Finland

Dry eye syndrome

5.0

307.7

1826

4100

CB9S4

NOMESCO Finland

Photography of eyelids and eyebrows

42.7

307.7

231

SPAT1153

SPAT

Removal of sutures

2.0

307.7

5322

32567

QAJ10

NOMESCO Finland

Browlift

94.6

307.7

296

CBJ40

NOMESCO Finland

Resection of levator muscle of eyelid

1008.2

307.7

392

CBJ50

NOMESCO Finland

Operation for ptosis of eyebrow

467.5

307.7

792

F16

ICPC

Eyelid symptom/complaint

3.9

307.7

1118

3022

CBB10

NOMESCO Finland

Excision of redundant skin of eyelid

1261.2

307.7

3669

ZXA10

NOMESCO Finland

Bilateral

4.5

307.7

5130

16234

H04.5

ICD-10 Finland

Stenosis and insufficiency of lacrimal passages

27.0

307.7

291

110

CBB11

NOMESCO Finland

Resection of lax skin in upper eyelid

1848.5

307.7

4452

H02.1

ICD-10 Finland

Ectropion of eyelid

93.6

307.7

248

S18

ICPC

Laceration/cut

1.9

301.7

7069

48770

WX002

NOMESCO Finland

Sedation and analgesia

2.1

284.1

3330

17912

XCC00

NOMESCO Finland

Investigative irrigation of lacrimal passages

25.1

265.6

186

CBJ30

NOMESCO Finland

Plastic repair of levator aponeurosis of eyelid

1310.2

264.2

257

3261

FHL

Skin excision

230.1

198.1

204

Z01.0

ICD-10 Finland

Examination of eyes and vision

2.0

188.5

2605

14604

H01.0

ICD-10 Finland

Blepharitis

3.2

186.1

760

2438

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.7

184.0

5036

34728

CBD00

NOMESCO Finland

Plastic reconstruction of eyelid using suture

75.9

182.5

H02.5

ICD-10 Finland

Other disorders affecting eyelid function

237.0

181.9

187

F29

ICPC

Eye symptom/complaint other

2.4

180.1

1428

6445

TCC30

NOMESCO Finland

Intubation of lacrimal canaliculus/duct

53.0

175.3

100

H02.8

ICD-10 Finland

Other specified disorders of eyelid

18.9

166.4

131

G47.3

ICD-10 Finland

Sleep apnoea

1.8

153.9

2998

18599

M79.6

ICD-10 Finland

Pain in limb

1.6

146.9

5729

42533

XCK10

NOMESCO Finland

Photography of fundus of eye

2.1

146.8

1501

7488

CBB30

NOMESCO Finland

Excision of lesion of eyelid

3.3

145.1

559

1727

H02.2

ICD-10 Finland

Lagophthalmos

24.8

143.6

101

M03BX02

ATC

tizanidine; oral

1.6

138.0

8017

64920

ZXD20

NOMESCO Finland

Day surgery

1.9

135.3

1880

10449

M54.5

ICD-10 Finland

Low back pain

1.6

130.4

4616

33223

CBN20

NOMESCO Finland

Shortening of eyelid retractors

327.8

129.7

131

S01GX01

ATC

cromoglicic acid; ophthalmic

1.8

128.0

2429

14855

A06AC01

ATC

ispaghula (psylla seeds); oral

1.6

127.5

3903

27099

CBB00

NOMESCO Finland

Excision of chalazion

20.8

125.9

N02AJ06

ATC

codeine and paracetamol; systemic

1.5

123.4

5427

40897

QAJ15

NOMESCO Finland

Browlift using video-endoscope

41.3

122.7

M01AH05

ATC

etoricoxib; oral

1.5

122.4

8077

66417

TCC10

NOMESCO Finland

Probing of lacrimal canaliculus/duct

37.7

121.5

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.8

121.5

2179

13087

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.5

121.0

5895

45369

A02BC05

ATC

esomeprazole; systemic

1.5

120.8

5647

43066

ZXE00

NOMESCO Finland

One hour or less

1.5

120.3

5076

37844

N02BE01

ATC

paracetamol; systemic, rectal

2.0

118.7

12094

110253

H00.1

ICD-10 Finland

Chalazion

4.0

116.6

333

840

H04.2

ICD-10 Finland

Epiphora

15.5

115.3

100

CBN99

NOMESCO Finland

Other operation on eyelid for malposition

297.2

115.3

117

R01AD09

ATC

mometasone; nasal

1.5

114.4

5578

42764

J01DB01

ATC

cefalexin; oral

1.7

113.9

10758

95090

CBN30

NOMESCO Finland

Shortening of canthal ligament

171.5

113.5

119

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.5

110.6

4901

36742

N02AX02

ATC

tramadol; systemic, rectal

1.5

108.7

5786

45018

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.6

108.5

3450

23998

CBJ41

NOMESCO Finland

Shortening of superior tarsal muscle (Müller's muscle)

537.4

107.9

107

N03AX16

ATC

[U] pregabalin

1.6

106.4

3278

22612

H01.80

ICD-10 Finland

Prolonged inflammation in the edge of the eyelid

9.8

106.0

122

125

J01FA10

ATC

azithromycin; systemic

1.5

103.4

6963

56579

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.5

102.1

4520

33728

N03AX12

ATC

[U] gabapentin; oral

1.7

101.2

2270

14443

L17

ICPC

Foot/toe symptom/complaint

1.5

100.7

3908

28336

L03

ICPC

Low back symptom/complaint

1.5

98.7

3547

25269

A02BC02

ATC

pantoprazole; systemic

1.5

97.8

9251

79969

H25.1

ICD-10 Finland

Senile nuclear cataract

1.5

96.9

4148

30659

WX100

NOMESCO Finland

Conjunctival surface anesthesia

1.7

96.4

1973

12230

J02AC01

ATC

fluconazole; systemic

1.5

94.5

5112

39556

N06AX11

ATC

mirtazapine; oral

1.5

94.5

4389

32949

M25.5

ICD-10 Finland

Pain in joint

1.5

93.9

3986

29365

R03AC02

ATC

salbutamol; inhalant

1.5

93.7

6880

56393

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.8

93.0

1498

8657

A98

ICPC

Health maint/preventive medicine

2.4

91.7

12857

121390

R51.80

ICD-10 Finland

Headache

1.7

91.6

1764

10738

R07.4

ICD-10 Finland

Chest pain, unspecified

1.5

90.9

3836

28187

SAA01

NOMESCO Finland

Simple examination of mouth

1.5

89.6

8620

74023

M01AB05

ATC

diclofenac; systemic, rectal

1.5

89.5

8496

72767

M54.4

ICD-10 Finland

Lumbago with sciatica

1.6

88.3

2267

14876

M48.0

ICD-10 Finland

Spinal stenosis

1.7

87.3

1881

11798

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.5

86.9

4927

38289

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.6

86.0

2615

17853

M70.6

ICD-10 Finland

Trochanteric bursitis

1.6

85.1

2053

13251

Z01.2

ICD-10 Finland

Dental examination

1.4

84.5

5355

42416

D23.1

ICD-10 Finland

Benign neoplasm: Skin of eyelid, including canthus

2.5

84.5

555

2282

S29

ICPC

Skin symptom/complaint other

1.6

84.4

2556

17426

M01AE01

ATC

ibuprofen; systemic, rectal

1.6

84.0

11492

105245

J01AA02

ATC

doxycycline; systemic

1.5

83.3

10304

92138

R06AX27

ATC

desloratadine; oral

1.5

83.1

3155

22596

TQW40, ,

SPAT

2.0

82.4

1016

5377

A02BC03

ATC

lansoprazole; oral

1.5

82.2

3918

29378

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.7

81.3

1828

11576

CBG00

NOMESCO Finland

Epilation of cilia by electrolysis

144.3

81.1

SAA02

NOMESCO Finland

Basic examination of mouth

1.4

80.8

7734

65705

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.5

79.0

2755

19347

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.6

78.3

2237

15018

ZXA05

NOMESCO Finland

Left side

1.5

78.0

3377

24792

H26.4

ICD-10 Finland

After-cataract

1.7

77.6

1546

9473

H02.9

ICD-10 Finland

Disorder of eyelid, unspecified

11.5

77.4

ZXD10

NOMESCO Finland

Scheduled procedure

1.4

77.1

4967

39268

N06AX21

ATC

duloxetine; oral

1.7

76.7

1475

8948

R06.5

ICD-10 Finland

Mouth breathing

1.9

76.4

1045

5721

H02AB06

ATC

prednisolone; systemic

1.4

75.7

6132

50380

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

2.0

75.6

904

4731

CBD99

NOMESCO Finland

Other plastic reconstruction of eyelid

103.2

74.9

R06.0

ICD-10 Finland

Dyspnoea

1.5

74.7

3558

26572

Z01.8

ICD-10 Finland

Other specified special examinations

1.5

74.6

2877

20604

M01AE02

ATC

naproxen; oral, rectal

1.4

73.9

6868

57655

CJB10

NOMESCO Finland

Laser discission of secondary cataract

1.8

73.5

1320

7850

N62

ICD-10 Finland

Hypertrophy of breast

2.3

72.8

565

2501

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

2.0

72.2

889

4697

N05CF02

ATC

zolpidem; oral

1.6

72.1

2218

15113

R01AD58

ATC

fluticasone, combinations; nasal

1.5

72.0

2535

17794

L08

ICPC

Shoulder symptom/complaint

1.5

71.8

2837

20396

J01MA02

ATC

ciprofloxacin; systemic

1.4

71.2

4985

39825

R06AE07

ATC

cetirizine; oral

1.4

71.0

5322

42997

H02.6

ICD-10 Finland

Xanthelasma of eyelid

23.3

70.6

UJF32

NOMESCO Finland

Coloscopy

1.4

70.6

3596

27141

S01XA18

ATC

ciclosporin; ophthalmic

7.5

70.6

101

136

P01AB01

ATC

metronidazole; oral, rectal

1.4

70.2

5086

40838

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.4

69.4

6133

50850

R01AD12

ATC

fluticasone furoate; nasal

1.4

69.3

3375

25247

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.4

69.0

7219

61480

G44.2

ICD-10 Finland

Tension-type headache

1.6

68.9

1614

10296

N05CF01

ATC

zopiclone; oral

1.4

68.9

4311

33730

E0000UV, ,

ATC

1.4

68.7

5105

41115

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

68.5

6137

50950

WX006

NOMESCO Finland

Intravenous sedation or analgesia without general anesthesia

2.0

68.2

808

4210

R05

ICPC

Cough

1.5

68.2

2987

21882

CBJ99

NOMESCO Finland

Other operation for ptosis

339.0

67.6

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.4

67.3

3858

29700

H06.2*E05.9

ICD-10 Finland

Dysthyroid exophthalmos

661.7

67.0

R5140

NOMESCO Finland

Monitoring the use of the aid

1.7

66.8

1348

8268

L15

ICPC

Knee symptom/complaint

1.5

66.6

3165

23534

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.7

66.6

1293

7849

ZXA00

NOMESCO Finland

Right side

1.4

66.2

3539

26891

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.6

66.1

1556

9934

L13

ICPC

Hip symptom/complaint

1.5

65.8

2625

18861

L82

ICD-10 Finland

Seborrhoeic keratosis

1.5

65.7

2534

18083

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.4

64.9

5324

43449

G04BD12

ATC

mirabegron; oral

1.6

64.6

1722

11327

M03BC01

ATC

orphenadrine (citrate); systemic

1.5

64.4

2558

18351

M01AE03

ATC

ketoprofen; systemic, rectal

1.4

64.2

4751

38116

J01CA04

ATC

amoxicillin; systemic

1.4

64.1

10073

91116

UKC02

NOMESCO Finland

Cystoscopy

1.5

63.6

2007

13715

C10AA07

ATC

rosuvastatin; oral

1.4

62.4

4309

34140

L01

ICPC

Neck symptom/complaint

1.6

62.3

1860

12553

D07AB02

ATC

hydrocortisone butyrate; topical

1.4

62.2

3565

27366

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.8

62.0

1046

6095

H57.1

ICD-10 Finland

Ocular pain

2.6

61.6

377

1498

E85.80

ICD-10 Finland

Meretoja sick

29.4

61.5

M01AC06

ATC

meloxicam; systemic, rectal

1.4

61.5

4818

38933

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.5

61.4

2598

18851

C08CA01

ATC

amlodipine; oral

1.4

61.3

5304

43533

ZXE10

NOMESCO Finland

More than one and less than three hours

1.4

61.2

4579

36722

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.4

61.2

6525

55287

R01AD08

ATC

fluticasone; nasal

1.4

60.9

3280

24886

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.4

60.3

5388

44400

M02AA07

ATC

piroxicam; topical

1.4

60.2

4835

39188

C10AA05

ATC

atorvastatin; oral

1.4

59.8

5759

47985

I10

ICD-10 Finland

Essential (primary) hypertension

1.4

59.7

8540

75516

WX199

NOMESCO Finland

Other local analgesia

2.2

59.7

494

2246

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.5

59.7

2522

18284

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.5

59.1

1926

13237

TQW40

NOMESCO Finland

Remowal of suture of skin

1.8

59.0

929

5303

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

1.8

58.5

879

4945

SFA10

NOMESCO Finland

One-surface restoration

1.3

58.1

6303

53376

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.6

58.1

1393

8917

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.6

57.7

1305

8232

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.3

55.7

4889

40031

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.4

55.2

3230

24788

A02BC01

ATC

omeprazole; systemic

1.4

54.8

3479

27056

CD2S4

NOMESCO Finland

Photography of eye

5.3

54.1

108

204

N81.6

ICD-10 Finland

Rectocele

1.7

53.9

1043

6309

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.4

53.6

3089

23622

J01DA01

ATC

[U] cefalexin

1.3

52.1

7556

66253

R05

ICD-10 Finland

Cough

1.4

52.1

2628

19626

R42

ICD-10 Finland

Dizziness and giddiness

1.4

52.0

2993

22867

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.6

51.3

1263

8126

R01BA52

ATC

pseudoephedrine, combinations; oral

1.4

50.9

3764

29927

A02BA02

ATC

ranitidine; systemic

1.4

50.8

2497

18550

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.4

50.5

2321

17029

TCW99

NOMESCO Finland

Other minor procedure in eye surgery

3.2

50.5

197

613

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.6

50.5

1272

8227

SFA20

NOMESCO Finland

Two-surface restoration

1.3

50.3

6608

57031

D07AC01

ATC

betamethasone; topical

1.3

50.2

4377

35655

CBN00

NOMESCO Finland

Eversion suture of eyelid

256.4

50.1

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

1.6

50.0

1116

7004

S21

ICPC

Skin texture symptom/complaint

1.5

49.8

1780

12435

A11

ICPC

Chest pain NOS

1.7

49.7

1057

6552

J02AC02

ATC

itraconazole; systemic

1.4

49.7

2191

15947

R74

ICPC

Upper respiratory infection acute

1.4

49.7

2955

22674

M03BC51

ATC

orphenadrine, combinations; systemic

1.4

49.5

3198

24868

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.4

49.1

3177

24705

M01AH01

ATC

celecoxib; oral

1.4

48.9

2383

17661

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

48.5

4198

34113

S15

ICPC

Foreign body in skin

1.8

48.5

806

4669

F51.0

ICD-10 Finland

Nonorganic insomnia

1.5

48.4

1565

10703

P06

ICPC

Sleep disturbance

1.6

48.4

1258

8193

SDA03

NOMESCO Finland

Periodontal treatment

1.3

48.3

4473

36705

NBG15

NOMESCO Finland

Acromioplastia, arthroscopic

1.8

48.0

812

4726

L57.0

ICD-10 Finland

Actinic keratosis

1.5

47.6

1489

10108

M79.1

ICD-10 Finland

Myalgia

1.5

47.5

1589

10943

H25.0

ICD-10 Finland

Senile incipient cataract

1.7

47.0

908

5486

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.6

46.9

1331

8841

S82

ICPC

Naevus/mole

1.5

46.9

1585

10935

N02BF01

ATC

gabapentin; oral

1.7

46.8

1009

6274

CBB15

NOMESCO Finland

Resection of herniated fat from eyelid

102.4

46.8

SDA02

NOMESCO Finland

Periodontal treatment, brief

1.3

46.7

3991

32334

H43.8

ICD-10 Finland

Other disorders of vitreous body

1.6

46.5

1270

8363

H10.3

ICD-10 Finland

Acute conjunctivitis, unspecified

1.9

46.3

645

3539

AA1AD

NOMESCO Finland

CT of head and brain

1.3

45.9

3505

27911

J01FA06

ATC

roxithromycin; oral

1.3

45.5

4849

40481

N40

ICD-10 Finland

Hyperplasia of prostate

1.4

45.1

2124

15618

G04CA02

ATC

tamsulosin; oral

1.4

45.1

2331

17428

N06AB04

ATC

citalopram; systemic

1.4

44.8

2503

18958

CBF99

NOMESCO Finland

Other operation for ectropion

98.4

44.8

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.4

44.7

2853

22086

N06AX16

ATC

venlafaxine; oral

1.5

44.5

1477

10148

N04BC05

ATC

pramipexole; oral

1.6

44.4

1026

6488

CBF10

NOMESCO Finland

Shortening of canthal ligaments and tarsal plate for ectropion

58.0

44.3

WX320

NOMESCO Finland

Spinalanesthesy

1.4

44.3

3086

24214

C07AB07

ATC

bisoprolol; oral

1.3

44.2

6512

56656

H02.7

ICD-10 Finland

Other degenerative disorders of eyelid and periocular area

64.0

44.1

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

1.6

44.1

1196

7858

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.5

44.0

1325

8912

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.6

43.7

994

6260

H02

ICPC

Hearing complaint

1.5

43.7

1840

13248

C10AX09

ATC

ezetimibe; oral

1.4

43.6

1984

14490

N01

ICPC

Headache

1.6

43.5

965

6040

K30

ICD-10 Finland

Functional dyspepsia

1.5

43.3

1345

9106

R35

ICD-10 Finland

Polyuria

1.7

43.2

786

4670

CCD60

NOMESCO Finland

Transnasal dacryocystorhinostomy

62.7

43.1

N39.3

ICD-10 Finland

Stress incontinence

1.6

43.1

1048

6709

D11

ICPC

Diarrhoea

1.6

43.1

1148

7510

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.4

42.9

2267

16994

J05AB01

ATC

aciclovir; systemic

1.4

42.8

2550

19504

R13

ICD-10 Finland

Dysphagia

1.7

42.7

841

5104

M01AX05

ATC

glucosamine; oral

1.4

42.4

2872

22413

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.5

41.9

1265

8508

WX408

NOMESCO Finland

General anesthesy, balanced

1.3

41.8

3082

24356

XKD00

NOMESCO Finland

Uroflowmetry

1.5

41.8

1662

11831

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.3

41.7

3227

25678

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.3

41.7

4674

39157

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.5

41.6

1307

8869

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

1.8

41.5

656

3741

L12

ICPC

Hand/finger symptom/complaint

1.4

41.5

1824

13230

D82

ICPC

Teeth/gum disease

1.3

41.3

3860

31544

Z41.1

ICD-10 Finland

Other plastic surgery for unacceptable cosmetic appearance

4.3

41.3

107

252

SFA30

NOMESCO Finland

Three-surface restoration

1.3

41.1

4922

41569

R02

ICPC

Shortness of breath/dyspnoea

1.5

40.7

1597

11335

H53.1

ICD-10 Finland

Subjective visual disturbances

1.7

40.6

791

4786

D06

ICPC

Abdominal pain localized other

1.6

40.5

986

6312

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

1.5

40.5

1365

9397

H29

ICPC

Ear symptom/complaint other

1.5

40.5

1403

9715

F03

ICPC

Eye discharge

1.8

40.4

680

3949

G04CB01

ATC

finasteride; oral

1.6

40.4

1081

7075

N06AA09

ATC

amitriptyline; systemic

1.5

40.4

1270

8616

C07AA05

ATC

propranolol; systemic

1.4

40.4

2202

16578

J05AB11

ATC

valaciclovir; oral

1.5

40.3

1673

11999

SPAT1263

SPAT

Sampling

1.3

40.2

4976

42160

H00.00

ICD-10 Finland

Hordeolum

2.1

40.2

386

1861

G51.0

ICD-10 Finland

Bell palsy

2.3

39.9

308

1361

C05AA08

ATC

fluocortolone; rectal, topical

1.4

39.7

1663

11945

QAJ30

NOMESCO Finland

Other facelift

6.0

39.5

115

M20.1

ICD-10 Finland

Hallux valgus (acquired)

1.5

39.4

1176

7885

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.3

39.4

2814

22102

C01DA14

ATC

isosorbide mononitrate; oral

1.4

39.3

1924

14213

H01

ICPC

Ear pain/earache

1.5

39.3

1153

7705

X59

ICD-10 Finland

Exposure to unspecified factor

1.4

39.2

2058

15386

R03AK07

ATC

formoterol and budesonide; inhalant

1.4

39.2

2259

17153

J31.0

ICD-10 Finland

Chronic rhinitis

1.6

39.1

889

5596

K03.64

ICD-10 Finland

Dental calculus supragingival

1.3

38.9

3202

25663

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

1.9

38.7

505

2714

CBC00

NOMESCO Finland

Suturation or/and revision of eyelid

10.3

38.6

M54.6

ICD-10 Finland

Pain in thoracic spine

1.7

38.6

776

4733

D06BX01

ATC

metronidazole; topical

1.5

38.3

1244

8494

R07.3

ICD-10 Finland

Other chest pain

1.5

38.2

1215

8257

J01FA09

ATC

clarithromycin; systemic

1.3

38.1

3558

29004

L86

ICPC

Back syndrome with radiating pain

1.7

38.1

739

4465

M54

ICD-10 Finland

Dorsalgia

1.5

38.1

1263

8661

H10.9

ICD-10 Finland

Conjunctivitis, unspecified

1.8

37.8

588

3336

SPAT1312

SPAT

General health counselling

1.3

37.8

3611

29525

R21

ICPC

Throat symptom/complaint

1.4

37.7

1787

13117

D01BA02

ATC

terbinafine; oral

1.3

37.6

2979

23725

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

1.6

37.5

845

5307

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

2.0

37.4

400

2007

J01EA01

ATC

trimethoprim; systemic

1.3

37.3

3325

26925

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.4

37.2

2182

16600

R53

ICD-10 Finland

Malaise and fatigue

1.3

37.2

2678

21032

N17

ICPC

Vertigo/dizziness

1.5

37.2

1517

10835

K02.1

ICD-10 Finland

Caries of dentine

1.3

37.1

6328

55559

M01AX17

ATC

nimesulide; oral

1.3

37.1

3130

25146

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.5

37.1

1431

10112

F45.8

ICD-10 Finland

Other somatoform disorders

1.8

36.9

571

3236

D01

ICPC

Abdominal pain/cramps general

1.5

36.9

1214

8310

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.6

36.8

925

5964

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.3

36.5

2717

21437

HAD30

NOMESCO Finland

Reduction mammoplasty with transposition of areola

1.9

36.4

444

2332

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

1.5

36.4

1120

7555

H13

ICPC

Plugged feeling ear

1.4

36.4

2372

18343

UDC00

NOMESCO Finland

Ear microscopy

1.6

36.2

861

5477

KMAK, ,

NOMESCO Finland

1.3

36.2

5515

47735

N05BA04

ATC

oxazepam; oral

1.3

36.1

3050

24491

UDQ12

NOMESCO Finland

Flexible laryngoscopy

1.7

35.9

650

3852

H10.0

ICD-10 Finland

Mucopurulent conjunctivitis

1.7

35.8

646

3825

Z71.8

ICD-10 Finland

Other specified counselling

1.3

35.8

3334

27129

J45.9

ICD-10 Finland

Asthma, unspecified

1.4

35.6

2201

16871

R05FA02

ATC

opium derivatives and expectorants; systemic

1.3

35.5

4883

41723

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.5

35.5

1420

10101

K07.60

ICD-10 Finland

Snapping jaw

1.9

35.2

483

2637

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.3

34.7

3671

30346

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.4

34.6

2100

16043

Z3231

NOMESCO Finland

Registered nurse

1.3

34.6

3171

25722

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.4

34.5

1649

12107

NGD05

NOMESCO Finland

Partial excision of meniscus of knee, arthroscopic

1.5

34.2

1350

9574

R03BA08

ATC

ciclesonide; inhalant

1.5

34.1

978

6494

R52.9

ICD-10 Finland

Pain, unspecified

1.5

34.1

1111

7583

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

1.7

34.1

644

3863

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.4

33.9

1499

10855

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.7

33.8

671

4077

TCC40

NOMESCO Finland

Closure of lacrimal canaliculus with plug

92.8

33.7

QAJ99

NOMESCO Finland

Other aesthetic operations on skin of head or neck

8.5

33.4

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.3

33.3

2815

22566

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.3

33.3

2365

18495

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

1.8

33.3

485

2699

CBB99

NOMESCO Finland

Other excision or destruction of lesion of eyelid

5.0

33.2

143

XCK00

NOMESCO Finland

Perimetry

1.6

33.1

746

4683

K08.80

ICD-10 Finland

Toothache NOS

1.6

33.0

837

5404

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.3

33.0

2417

18986

N06AB10

ATC

escitalopram; oral

1.4

32.9

1954

14865

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.7

32.9

610

3640

TPH04

NOMESCO Finland

Cathetrisation of vein

1.3

32.8

2547

20172

SDA01

NOMESCO Finland

Periodontal treatment, very brief

1.3

32.6

2827

22730

WX290

NOMESCO Finland

Other blockage of nerve

1.3

32.6

4482

38183

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.3

32.5

3084

25100

SCA01

NOMESCO Finland

Preventive oral health care, short

1.3

32.5

2769

22214

H00.03

ICD-10 Finland

Preseptal cellulite in the eyelid

8.9

32.4

G04CA01

ATC

alfuzosin; oral

1.5

32.4

1149

7977

Z2221

NOMESCO Finland

Medical doctor

1.3

32.3

3058

24874

CBG99

NOMESCO Finland

Other operation for trichiasis

+∞

32.3

L02

ICPC

Back symptom/complaint

1.5

32.3

1027

6973

C09CA06

ATC

candesartan; oral

1.3

32.3

2869

23145

SPAT1325

SPAT

Vaccination

1.3

32.2

4199

35546

L16

ICPC

Ankle symptom/complaint

1.5

32.0

1240

8756

C03CA01

ATC

furosemide; systemic

1.3

31.8

3906

32814

D02

ICPC

Abdominal pain epigastric

1.6

31.7

684

4245

N95.1

ICD-10 Finland

Menopausal and female climacteric states

1.5

31.7

1242

8791

N07BA03

ATC

varenicline; oral

1.9

31.5

436

2387

L57.4

ICD-10 Finland

Cutis laxa senilis

5.7

31.5

102

R03DC03

ATC

montelukast; oral

1.4

31.5

1779

13420

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.5

31.5

1114

7729

-1, ,

NOMESCO Finland

1.3

31.5

3293

27120

D19

ICPC

Teeth/gum symptom/complaint

1.3

31.4

2903

23528

R06AX22

ATC

ebastine; oral

1.4

31.3

1819

13782

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.4

31.0

1407

10229

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.4

30.8

1659

12414

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.4

30.8

1452

10626

H10.4

ICD-10 Finland

Chronic conjunctivitis

3.8

30.7

246

CBE20

NOMESCO Finland

Shortening of eyelid retractors for entropion

160.4

30.7

C08CA13

ATC

lercanidipine; oral

1.4

30.6

1886

14422

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.4

30.6

1394

10140

C10AA01

ATC

simvastatin; oral

1.2

30.5

5714

50279

S54

ICPC

Skin, Repair/fix-suture/cast/prosth device

1.9

30.5

377

1991

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.5

30.5

988

6732

H35.30

ICD-10 Finland

Kuhnt-Junius degeneration

1.6

30.4

723

4596

R60.0

ICD-10 Finland

Localized oedema

1.4

30.4

1519

11226

U02

ICPC

Urinary frequency/urgency

1.4

30.4

1756

13292

C09CA01

ATC

losartan; oral

1.3

30.3

3307

27353

M54.3

ICD-10 Finland

Sciatica

1.6

30.2

691

4354

M79.0

ICD-10 Finland

Rheumatism, unspecified

1.8

30.1

432

2393

M47.9

ICD-10 Finland

Spondylosis, unspecified

1.9

30.1

409

2228

CBF20

NOMESCO Finland

Resection of part of tarsus for ectropion

58.5

30.1

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.4

30.0

1557

11576

S46.0

ICD-10 Finland

Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder

1.5

30.0

987

6744

M47.82

ICD-10 Finland

Other spondylosis, cervical region

1.7

30.0

507

2948

R05FB02

ATC

cough suppressants and expectorants; systemic

1.2

30.0

4668

40234

G24.5

ICD-10 Finland

Blepharospasm

5.6

29.9

100

G04BD08

ATC

solifenacin; oral

1.5

29.9

866

5759

WX402

NOMESCO Finland

General anaesthesia

1.3

29.8

2301

18181

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.3

29.7

1950

15045

Z3229

NOMESCO Finland

Other healthcare associate professional

1.5

29.7

946

6422

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.2

29.6

5096

44383

SPAT1043

SPAT

Audiometry

1.4

29.5

1309

9470

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.5

29.5

1000

6873

SPAT1212

SPAT

Extensive examination of musculoskeletal system

1.5

29.5

888

5955

M01AH02

ATC

rofecoxib; oral

1.4

29.5

1635

12287

M77.4

ICD-10 Finland

Metatarsalgia

1.6

29.4

647

4036

SPAT1058

SPAT

PEF monitoring instruction

1.5

29.4

984

6749

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.5

29.2

1133

7997

N06AB03

ATC

fluoxetine; oral

1.4

29.2

1359

9916

SDA04

NOMESCO Finland

Demanding periodontal treatment

1.3

29.2

2848

23212

UJF30

NOMESCO Finland

Ileoscopy through colon

1.4

29.0

1166

8288

H04.4

ICD-10 Finland

Chronic inflammation of lacrimal passages

66.1

28.9

J01AA07

ATC

tetracycline; systemic

1.4

28.8

1381

10127

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.5

28.5

1078

7571

H03AA01

ATC

levothyroxine sodium; systemic

1.3

28.5

2970

24395

H16.0

ICD-10 Finland

Corneal ulcer

1.8

28.4

408

2260

WZA90

NOMESCO Finland

Other medical or dental certificate

1.3

28.3

2489

19999

H02AB07

ATC

prednisone; oral

1.4

28.3

1593

11995

SPAT1310

SPAT

Counselling related to known health issue

1.3

28.3

3687

31096

DFF00

NOMESCO Finland

Pure tone audiometry

1.4

28.3

1196

8577

CBJ90

NOMESCO Finland

Adjustment of ptosis of suture

+∞

28.1

N06AB06

ATC

sertraline; oral

1.5

27.7

1048

7361

R83

ICPC

Respiratory infection other

1.3

27.7

2076

16319

SPAT1301

SPAT

No procedures

1.3

27.6

3733

31602

EB1VA, ,

NOMESCO Finland

1.4

27.6

1285

9375

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.4

27.5

1191

8575

H10

ICD-10 Finland

Conjunctivitis

1.6

27.5

594

3688

Z3226

NOMESCO Finland

Physiotherapist

1.3

27.4

2083

16405

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.2

27.3

3756

31844

M54.2

ICD-10 Finland

Cervicalgia

1.5

27.3

802

5349

LEF03

NOMESCO Finland

Posterior colporrpahy with sutures for primary rectocele

1.7

27.2

561

3442

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.5

27.2

970

6734

R20.2

ICD-10 Finland

Paraesthesia of skin

1.6

27.1

695

4496

F01

ICPC

Eye pain

2.1

27.0

271

1330

B01AC04

ATC

clopidogrel; oral

1.3

27.0

1960

15331

R06AE09

ATC

levocetirizine; oral

1.4

27.0

1420

10573

L60.0

ICD-10 Finland

Ingrowing nail

1.7

26.9

493

2931

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.4

26.9

1686

12904

A01

ICPC

Pain general/multiple sites

1.5

26.9

1048

7401

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

1.6

26.8

697

4525

R51

ICD-10 Finland

Headache

1.7

26.7

497

2967

SAA04

NOMESCO Finland

Special examination of mouth

1.7

26.7

517

3121

L14

ICPC

Leg/thigh symptom/complaint

1.5

26.7

922

6361

A02BC04

ATC

rabeprazole; oral

1.5

26.5

958

6669

I49.3

ICD-10 Finland

Ventricular premature depolarization

1.5

26.3

816

5506

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.3

26.3

2316

18597

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

1.7

26.2

448

2613

D01AE16

ATC

amorolfine; topical

1.4

26.2

1415

10579

N03AE01

ATC

clonazepam; systemic

1.6

26.0

621

3952

J01DA09

ATC

[U] cefadroxil

1.3

26.0

2837

23395

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.3

25.9

1814

14109

CCA20

NOMESCO Finland

Incision of lacrimal punctum or canaliculus

40.1

25.8

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.4

25.7

1248

9165

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

2.0

25.6

284

1447

R03BA02

ATC

budesonide; inhalant

1.3

25.6

1939

15250

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.5

25.5

933

6510

L72.1

ICD-10 Finland

Trichilemmal cyst

1.5

25.4

719

4755

J34.2

ICD-10 Finland

Deviated nasal septum

1.7

25.4

462

2743

K59.0

ICD-10 Finland

Constipation

1.6

25.3

634

4079

J20

ICD-10 Finland

Acute bronchitis

1.4

25.3

1086

7804

CBA10

NOMESCO Finland

Biopsy of eyelid

2.9

25.3

121

426

CBN50

NOMESCO Finland

Excision of tarsus and skin

35.6

25.2

R12

ICD-10 Finland

Heartburn

1.5

25.0

865

5967

XF402

NOMESCO Finland

ECG with work load test

1.4

25.0

1267

9372

L04

ICPC

Chest symptom/complaint

1.6

24.9

665

4342

M20.4

ICD-10 Finland

Other hammer toe(s) (acquired)

1.6

24.8

584

3702

WX723

NOMESCO Finland

CPAP therapy

1.8

24.8

394

2252

H05.2

ICD-10 Finland

Exophthalmic conditions

70.0

24.8

H40.0

ICD-10 Finland

Glaucoma suspect

1.4

24.7

960

6775

CBE00

NOMESCO Finland

Suture of eyelid for entropion

250.7

24.7

M03AX01

ATC

botulinum toxin; parenteral

3.0

24.6

108

362

CBJ00

NOMESCO Finland

Suture of eyelid for ptosis

90.2

24.6

R51.81

ICD-10 Finland

Facial pain NOS

2.1

24.6

248

1220

I84.9

ICD-10 Finland

Unspecified hemorrhoids without complication

1.6

24.6

554

3477

H10.1

ICD-10 Finland

Acute atopic conjunctivitis

2.1

24.5

226

1076

D07AC13

ATC

mometasone; topical

1.2

24.4

3216

27074

R06AX13

ATC

loratadine; oral

1.4

24.4

1460

11087

XCX10

NOMESCO Finland

Other photography of eye

8.2

24.3

H93.1

ICD-10 Finland

Tinnitus

1.5

24.2

746

5025

N06AX26

ATC

vortioxetine; oral

1.6

24.2

589

3765

J01AA04

ATC

lymecycline; systemic

1.4

24.1

1158

8484

S01GX08

ATC

ketotifen; ophthalmic

1.8

24.1

383

2189

H04.3

ICD-10 Finland

Acute and unspecified inflammation of lacrimal passages

5.5

24.1

H25.8

ICD-10 Finland

Other senile cataract

1.4

24.0

1416

10728

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.4

24.0

1061

7664

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.5

24.0

827

5702

SDE02

NOMESCO Finland

Periodontal treatment by dental hygienist

1.3

23.9

2510

20570

N05CD07

ATC

temazepam; oral

1.4

23.9

1401

10602

XKC03

NOMESCO Finland

Water cystometry

1.8

23.9

374

2128

H02AB04

ATC

methylprednisolone; systemic

1.3

23.9

1645

12755

M79.7

ICD-10 Finland

Fibromyalgia

1.8

23.8

370

2100

SPAT1053

SPAT

Memory test

1.3

23.8

1887

14920

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.3

23.7

2620

21600

SPAT1249

SPAT

Treatment-related counselling outside office

1.2

23.7

4466

39000

ABC56

NOMESCO Finland

Decompression of lumbar spinal canal and nerve roots

1.8

23.7

333

1834

CCD50

NOMESCO Finland

Dacryocystorhinostomy with insertion of tube

240.4

23.6

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

1.5

23.6

769

5241

Z02.4

ICD-10 Finland

Examination for driving licence

1.2

23.5

3267

27639

C10AA03

ATC

pravastatin; oral

1.5

23.5

896

6296

R01AD01

ATC

beclometasone; nasal

1.3

23.5

1608

12452

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

1.5

23.5

725

4886

J01MA06

ATC

norfloxacin; oral

1.3

23.4

1567

12095

J01FF01

ATC

clindamycin; systemic

1.2

23.4

3001

25165

A97

ICPC

No disease

1.3

23.3

1951

15531

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

1.6

23.3

520

3254

S01GX09

ATC

olopatadine; ophthalmic

2.0

23.3

266

1369

S04

ICPC

Lump/swelling localized

1.4

23.3

1073

7806

H19.8*E85.80

ICD-10 Finland

Reticular keratitis in Meretoja's patients

28.2

23.1

XCH00

NOMESCO Finland

Eye pressure measurement

1.6

23.1

533

3364

A03FA02

ATC

cisapride; oral, rectal

1.4

23.1

890

6270

D07AD01

ATC

clobetasol; topical

1.3

23.0

1917

15251

A04

ICPC

Weakness/tiredness general

1.3

23.0

1547

11947

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.5

22.8

757

5179

XKD03

NOMESCO Finland

Urethral pressure profilometry

1.9

22.8

299

1612

SPAT1260

SPAT

Consultation of another employee

1.3

22.8

2032

16310

H81

ICPC

Excessive ear wax

1.3

22.7

2025

16249

G04BD07

ATC

tolterodine; oral

1.6

22.7

611

3997

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.3

22.7

2293

18692

CBE40

NOMESCO Finland

Combined correction of entropion

230.4

22.6

L28

ICPC

Limited function/disability (L)

1.3

22.5

2200

17857

G04BD11

ATC

fesoterodine; oral

1.8

22.5

370

2137

M67.4

ICD-10 Finland

Ganglion

1.5

22.4

683

4589

N06AX12

ATC

bupropion; oral

1.6

22.3

465

2861

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

1.5

22.3

830

5806

I83.9

ICD-10 Finland

Varicose veins of lower extremities without ulcer or inflammation

1.4

22.3

1268

9546

S22

ICPC

Nail symptom/complaint

1.5

22.3

700

4734

N30.0

ICD-10 Finland

Acute cystitis

1.3

22.2

1919

15332

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.2

22.2

2738

22836

XQ800

NOMESCO Finland

Prick test

1.5

22.2

643

4274

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.4

22.2

1315

9965

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.3

22.1

2527

20896

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.3

22.1

1578

12287

WZC00

NOMESCO Finland

Treatment plan or consultation

1.2

22.1

4072

35425

SXA20

NOMESCO Finland

Local application of medicine to mouth

1.6

22.0

488

3050

R4110, ,

SPAT

1.4

21.9

1025

7474

K85

ICPC

Elevated blood pressure

1.3

21.9

2046

16513

CBF30

NOMESCO Finland

Excision of tarsus and skin for ectropion

+∞

21.9

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.4

21.9

872

6180

Z42.0

ICD-10 Finland

Follow-up care involving plastic surgery of head and neck

6.3

21.8

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.4

21.8

880

6253

N07CA01

ATC

betahistine; oral

1.4

21.7

866

6138

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.3

21.7

1581

12345

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.2

21.6

2834

23791

R52.2

ICD-10 Finland

Other chronic pain

1.7

21.6

384

2266

R4110

NOMESCO Finland

Physiotherapy

1.2

21.6

3208

27291

G04CA52

ATC

tamsulosin and dutasteride; systemic

1.4

21.6

912

6531

N05BA01

ATC

diazepam; systemic, rectal

1.3

21.5

1434

11055

R09

ICPC

Sinus symptom/complaint

1.5

21.5

744

5131

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

1.6

21.5

482

3021

A01AB09

ATC

miconazole; local oral

1.4

21.5

995

7243

SXC05

NOMESCO Finland

Other oral or dental procedure

1.6

21.4

568

3703

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

1.3

21.4

1446

11167

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.4

21.4

1079

7968

K59.1

ICD-10 Finland

Functional diarrhoea

1.5

21.4

599

3955

A07AA02

ATC

nystatin; oral

1.5

21.4

689

4686

A54

ICPC

General and Unspecified, Repair/fix-suture/cast/prosth device

2.1

21.3

198

946

CBH25

NOMESCO Finland

Tarsorrhaphy

26.4

21.3

G50.1

ICD-10 Finland

Atypical facial pain

2.1

21.2

192

909

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.2

21.2

2848

23968

J01CA08

ATC

pivmecillinam; oral

1.2

21.1

5113

45582

M15

ICD-10 Finland

Polyarthrosis

1.5

21.1

658

4444

SPAT1097

SPAT

Recording of ECG

1.3

21.1

1775

14130

R01AD11

ATC

triamcinolone; nasal

1.4

21.0

900

6463

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.5

21.0

670

4548

G04BD09

ATC

trospium; oral

1.8

20.9

326

1854

K03.00

ICD-10 Finland

Approximal wear

1.5

20.9

624

4176

R03BB04

ATC

tiotropium bromide; inhalant

1.4

20.9

1120

8352

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.2

20.8

4583

40484

H062, E050,

ICD-10 Finland

+∞

20.8

CBK11

NOMESCO Finland

Operation for lagophtalmus with implant

17.8

20.8

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.4

20.7

867

6197

H01.1

ICD-10 Finland

Noninfectious dermatoses of eyelid

4.5

20.7

108

G04BD04

ATC

oxybutynin; oral, transdermal

1.5

20.7

637

4290

U07

ICPC

Urine symptom/complaint other

1.4

20.7

868

6208

F05

ICPC

Visual disturbance other

1.8

20.7

316

1787

K03.65

ICD-10 Finland

Deposits [accretions] on teeth betel

1.3

20.7

2154

17606

VALMI, ,

NOMESCO Finland

1.3

20.6

2304

18990

A99

ICPC

Disease/condition unspecnature/site

1.4

20.4

1025

7560

L90.5

ICD-10 Finland

Scar conditions and fibrosis of skin

2.7

20.4

108

402

R30.0

ICD-10 Finland

Dysuria

1.7

20.4

409

2494

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.3

20.4

1813

14530

UJD02

NOMESCO Finland

Gastroscopy

1.6

20.4

524

3394

A03CA02

ATC

clidinium and psycholeptics; oral

1.5

20.3

695

4782

H53.2

ICD-10 Finland

Diplopia

1.8

20.3

316

1796

QAA25

NOMESCO Finland

Destruction of lesion of head or neck

1.8

20.3

305

1716

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.3

20.3

1597

12595

H10.5

ICD-10 Finland

Blepharoconjunctivitis

2.3

20.2

153

673

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.3

20.1

1319

10139

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

1.7

20.1

352

2070

ENC30

NOMESCO Finland

Plastic operation of pharynx

2.4

20.1

134

558

Z01.9

ICD-10 Finland

Special examination, unspecified

1.5

20.1

649

4416

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.5

20.1

645

4384

S01KA02

ATC

hypromellose; ophthalmic

2.0

20.0

215

1084

R96

ICPC

Asthma

1.4

20.0

1076

8024

U01

ICPC

Dysuria/painful urination

1.4

20.0

862

6193

-59

ICPC

Other therap proced/minor surg NEC

1.8

20.0

300

1687

DAX08

NOMESCO Finland

Fitting of hearing aid

1.5

20.0

628

4247

SBB10

NOMESCO Finland

Dental impressions

1.6

20.0

517

3352

H60

ICD-10 Finland

Otitis externa

1.6

20.0

449

2816

CA1CG

NOMESCO Finland

Eye and orbita extensive MRI examination with high intensity magnet

3.4

20.0

210

NAG40

NOMESCO Finland

Anterior fusion of cervical spine without fixation

1.9

20.0

232

1202

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.4

19.9

786

5558

WX720

NOMESCO Finland

Own respiration

1.6

19.9

487

3117

A02BA04

ATC

nizatidine; systemic

1.4

19.9

869

6259

M01AG02

ATC

tolfenamic acid; oral, rectal

1.3

19.9

1548

12188

D07CC01

ATC

betamethasone and antibiotics; topical

1.3

19.9

1295

9947

H92.0

ICD-10 Finland

Otalgia

1.5

19.8

535

3502

CBG20

NOMESCO Finland

Plastic repair of margin of eyelid for trichiasis

+∞

19.8

X58

ICD-10 Finland

Exposure to other specified factors

1.3

19.8

1286

9873

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.4

19.8

881

6368

F13

ICPC

Eye sensation abnormal

1.8

19.7

274

1505

3269

FHL

Other measure in this category

73.6

19.7

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

1.5

19.6

736

5157

R03BA01

ATC

beclometasone; inhalant

1.3

19.6

1552

12249

CBB12

NOMESCO Finland

Resection of lax skin in lower eyelid

105.2

19.6

CBB23

NOMESCO Finland

Correction of lax skin and resection of herniated fat in lower eyelid, open procedure

105.2

19.6

M20.2

ICD-10 Finland

Hallux rigidus

1.7

19.5

383

2323

K59.09

ICD-10 Finland

Constipation, unspecified

1.4

19.5

743

5222

WX780

NOMESCO Finland

Remote monitoring CPAP

1.7

19.4

394

2410

DJD20

NOMESCO Finland

Plastic repair of septum of nose

1.8

19.4

297

1682

G55.1*M51.1

ICD-10 Finland

Compression of nerve roots and nerve plexus in disc diseases in the lumbar region and other regions

1.9

19.3

248

1330

LEG10

NOMESCO Finland

Vaginal urethrocystopexy

1.8

19.3

313

1802

R75

ICPC

Sinusitis acute/chronic

1.6

19.2

448

2837

M02AA10

ATC

ketoprofen; topical

1.3

19.2

1870

15149

K02.0

ICD-10 Finland

Caries limited to enamel

1.3

19.1

1425

11149

SPAT1336

SPAT

Request for examination

1.6

19.1

395

2427

M54.8

ICD-10 Finland

Other dorsalgia

1.6

19.1

440

2777

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

1.7

19.1

368

2222

H03.1*B02.3

ICD-10 Finland

Zoster blepharitis

20.0

19.0

Z01.7

ICD-10 Finland

Laboratory examination

1.3

19.0

1502

11847

JHB00

NOMESCO Finland

Hemorrhoidectomy

1.7

19.0

357

2141

M19.9

ICD-10 Finland

Arthrosis, unspecified

1.5

19.0

513

3361

R01AD05

ATC

budesonide; nasal

1.4

19.0

766

5441

S01GX02

ATC

levocabastine; ophthalmic

1.5

18.9

532

3517

XF404

NOMESCO Finland

Ambulatory ECG

1.4

18.9

991

7362

SDE03

NOMESCO Finland

Periodontal treatment by dental hygienist, extensive

1.2

18.8

2442

20435

N05AH04

ATC

quetiapine; oral

1.3

18.8

1554

12328

G56.2

ICD-10 Finland

Lesion of ulnar nerve

1.8

18.8

302

1735

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

1.7

18.7

334

1975

CBG10

NOMESCO Finland

Cryotherapy for trichiasis

27.8

18.7

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.3

18.5

1275

9864

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.4

18.5

778

5564

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

1.2

18.5

2518

21176

JBC01

NOMESCO Finland

Laparoscopic gastro-oesophageal antireflux operation

2.0

18.4

210

1082

F99

ICPC

Eye/adnexa disease other

2.9

18.4

284

S01AA01

ATC

chloramphenicol; ophthalmic

1.6

18.3

478

3108

XJH00

NOMESCO Finland

Transanal ultrasonography

1.5

18.3

552

3704

M19.8

ICD-10 Finland

Other specified arthrosis

1.6

18.2

443

2833

N02BF02

ATC

pregabalin; oral

1.5

18.1

595

4061

R15

ICD-10 Finland

Faecal incontinence

1.7

18.1

356

2161

M15.0

ICD-10 Finland

Primary generalized (osteo)arthrosis

1.6

18.0

394

2456

L90

ICPC

Osteoarthrosis of knee

1.4

18.0

851

6213

UJH02

NOMESCO Finland

Anoscopy

1.6

18.0

442

2834

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

1.5

18.0

516

3425

A01AB04

ATC

amphotericin B; local oral

1.5

18.0

543

3644

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.3

18.0

1684

13570

N05BA12

ATC

alprazolam; oral

1.3

18.0

1065

8062

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

1.3

18.0

1359

10653

H91.1

ICD-10 Finland

Presbycusis

1.4

17.9

755

5402

P20

ICPC

Memory disturbance

1.3

17.9

1686

13591

M51.9

ICD-10 Finland

Intervertebral disc disorder, unspecified

2.2

17.8

155

723

K03.80

ICD-10 Finland

Irradiated enamel

1.6

17.8

473

3087

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

1.9

17.8

204

1054

H35.38

ICD-10 Finland

Preretinal fibrosis of the macula

1.6

17.8

429

2739

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.2

17.8

3327

28860

S06.0

ICD-10 Finland

Concussion

1.4

17.8

1029

7762

R29

ICPC

Respiratory symptom/complaint other

1.5

17.7

663

4643

CBE99

NOMESCO Finland

Other operation for entropion

+∞

17.7

SFA00

NOMESCO Finland

Small restoration

1.3

17.7

1389

10944

DAX00

NOMESCO Finland

Adjustment or review of hearing aid

1.5

17.6

579

3953

J30.0

ICD-10 Finland

Vasomotor rhinitis

1.8

17.6

266

1501

M01AB55

ATC

diclofenac, combinations; oral

1.4

17.6

793

5744

S01

ICPC

Pain/tenderness of skin

1.5

17.6

473

3097

P03

ICPC

Feeling depressed

1.4

17.4

686

4853

WYA10

NOMESCO Finland

Emergency care or similar visit

1.4

17.4

675

4761

J01CE02

ATC

phenoxymethylpenicillin; oral

1.2

17.3

7454

69269

NHU20

NOMESCO Finland

Removal of internal fixation device from ankle or foot

1.6

17.3

449

2915

R03BA05

ATC

fluticasone; inhalant

1.3

17.3

1881

15422

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

1.6

17.3

435

2806

Z00.0

ICD-10 Finland

General medical examination

1.2

17.2

2051

16990

ACC51

NOMESCO Finland

Release of median nerve

1.4

17.2

809

5902

H02

ICD-10 Finland

Other disorders of eyelid

6.2

17.2

H53.9

ICD-10 Finland

Visual disturbance, unspecified

1.6

17.2

364

2253

S20.2

ICD-10 Finland

Contusion of thorax

1.5

17.2

494

3282

M50.3

ICD-10 Finland

Other cervical disc degeneration

1.8

17.1

258

1455

K80

ICPC

Cardiac arrhythmia NOS

1.4

17.1

941

7042

F32

ICD-10 Finland

Depressive episode

1.6

17.1

413

2639

N64.4

ICD-10 Finland

Mastodynia

1.7

17.1

285

1656

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.3

17.0

1097

8411

S83.2

ICD-10 Finland

Tear of meniscus, current

1.5

16.9

627

4386

D20

ICPC

Mouth/tongue/lip symptom/complaint

1.5

16.9

456

2989

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.4

16.8

781

5686

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.3

16.8

1485

11875

N06AA12

ATC

doxepin; systemic

1.5

16.8

570

3919

R60.9

ICD-10 Finland

Oedema, unspecified

1.5

16.8

618

4316

N06AG02

ATC

moclobemide; oral

1.5

16.8

451

2953

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.4

16.8

647

4558

EMAK, ,

NOMESCO Finland

1.7

16.7

330

2005

NBL00

NOMESCO Finland

Suture or reinsertation of rotator cuff of shoulder

1.5

16.7

587

4062

C03AA03

ATC

hydrochlorothiazide; oral

1.3

16.7

1132

8737

I20.99

ICD-10 Finland

Angina pectoris, unspecified

1.4

16.7

701

5015

H01.9

ICD-10 Finland

Inflammation of eyelid, unspecified

2.5

16.7

104

421

QBJ30

NOMESCO Finland

Correction of abdominal apron

2.9

16.6

273

JN3AD

NOMESCO Finland

Abdominal CT examination

1.3

16.6

1224

9557

H11.3

ICD-10 Finland

Conjunctival haemorrhage

1.5

16.6

459

3023

M75.9

ICD-10 Finland

Shoulder lesion, unspecified

1.5

16.6

489

3266

S01AD03

ATC

aciclovir; ophthalmic

1.7

16.6

322

1950

LEG12

NOMESCO Finland

Transobturatoric tape

2.0

16.5

185

949

H06.2

ICD-10 Finland

Dysthyroid exophthalmos

170.2

16.5

D12

ICPC

Constipation

1.6

16.4

378

2387

I25

ICD-10 Finland

Chronic ischaemic heart disease

1.5

16.4

507

3419

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.3

16.3

1804

14809

NBF25

NOMESCO Finland

Operation for humeroscapular osteochondritis, arthroscopic

1.8

16.3

225

1236

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

1.5

16.3

600

4190

QAE20

NOMESCO Finland

Excision and repair of scar or web of skin of head or neck

3.5

16.3

158

U71

ICPC

Cystitis/urinary infection other

1.4

16.2

749

5446

C10AA04

ATC

fluvastatin; oral

1.3

16.2

1044

7999

K86

ICPC

Hypertension uncomplicated

1.3

16.1

1601

12983

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.2

16.1

2006

16687

J45

ICD-10 Finland

Asthma

1.3

16.1

1041

7981

H20.0

ICD-10 Finland

Acute and subacute iridocyclitis

1.7

16.0

323

1974

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.2

16.0

1933

16024

M19.1

ICD-10 Finland

Post-traumatic arthrosis of other joints

1.7

16.0

283

1671

M75

ICD-10 Finland

Shoulder lesions

1.5

16.0

432

2831

S08

ICPC

Skin colour change

1.5

15.8

582

4062

H02BX01

ATC

methylprednisolone, combinations; systemic

1.4

15.8

592

4146

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.2

15.8

2072

17326

QA4S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in face

3.2

15.8

196

L19

ICPC

Muscle symptom/complaint NOS

1.7

15.8

273

1603

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.4

15.7

813

6022

R06AX26

ATC

fexofenadine; oral

1.4

15.7

601

4226

M76.6

ICD-10 Finland

Achilles tendinitis

1.5

15.7

475

3189

QAJ20

NOMESCO Finland

Subperiosteal facelift

33.4

15.7

R03AK11

ATC

formoterol and fluticasone; inhalant

1.8

15.7

251

1441

R31

ICD-10 Finland

Unspecified haematuria

1.3

15.7

1009

7728

H00.01

ICD-10 Finland

Abscess of the eyelid

7.2

15.7

C09DA06

ATC

candesartan and diuretics; oral

1.4

15.6

871

6529

3281

FHL

Upper eyelid reconstruction surgery

+∞

15.6

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.4

15.6

802

5935

R07.0

ICD-10 Finland

Pain in throat

1.5

15.6

547

3784

H52.4

ICD-10 Finland

Presbyopia

1.7

15.6

275

1623

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

1.4

15.6

836

6230

DHB50

NOMESCO Finland

Turbinoplasty

1.9

15.6

202

1089

KE1BE

NOMESCO Finland

Rectal ultrasound examinaiton of prostata

1.4

15.5

723

5264

K57

ICD-10 Finland

Diverticular disease of intestine

1.7

15.5

255

1475

U07.2

ICD-10 Finland

COVID-19, virus not identified

1.3

15.5

1200

9429

R08

ICPC

Nose symptom/complaint other

1.7

15.5

302

1832

J01FA15

ATC

telithromycin; oral

1.3

15.5

982

7508

D12.5

ICD-10 Finland

Benign neoplasm: Sigmoid colon

1.5

15.4

474

3193

D06BB03

ATC

aciclovir; topical

1.5

15.4

477

3218

SFA40

NOMESCO Finland

Restoration involving the entire crown of the tooth

1.2

15.4

2469

21066

M51.8

ICD-10 Finland

Other specified intervertebral disc disorders

2.2

15.4

123

556

EB1AA, ,

SPAT

1.4

15.4

610

4320

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

1.3

15.4

1186

9316

XKD06

NOMESCO Finland

Physiologic investigation of micturition

1.7

15.3

282

1684

S01GX05

ATC

lodoxamide; ophthalmic

2.2

15.3

129

596

SPAT1377

SPAT

Polysomnography

1.6

15.3

324

2007

XG466

NOMESCO Finland

Sleep oxymetry

1.7

15.2

301

1832

M17.3

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

11816

105548

1.99

143.98

5.7

5.0

1.96

2.09

mu/l

2.48

10760

95382

(3013707) Erythrocyte sedimentation rate by Westergren method

10055

86439

1.65

130.33

4.6

4.2

12.50

13.85

mm/h

17.86

9259

79150

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

10136

88404

1.60

112.22

4.6

4.2

14.88

14.97

pmol/l

3.29

9155

79383

(3037467) Urinalysis macro (dipstick) panel - Urine

9339

79959

1.55

112.09

5.1

4.5

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

11756

106771

1.80

108.76

6.8

6.1

40.19

40.28

mmol/mol

0.52

10777

97336

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

12382

114401

2.04

107.81

6.0

5.3

2.69

2.73

mmol/l

5.32

11311

103813

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

12227

112488

1.96

107.67

16.4

15.4

22.53

24.63

mg/l

9.67

9941

90072

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

12150

111802

1.90

103.13

5.5

4.9

5.98

6.00

mmol/l

1.22

10998

100542

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

10360

91560

1.57

100.71

7.4

7.7

76.25

79.93

u/l

12.84

9704

85801

(3019550) Sodium [Moles/volume] in Serum or Plasma

12699

118844

2.24

100.43

19.6

18.0

139.71

139.70

mmol/l

0.08

12432

115797

(3023103) Potassium [Moles/volume] in Serum or Plasma

12715

119081

2.25

99.90

19.7

18.1

3.97

mmol/l

0.14

12433

115824

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

12115

111757

1.85

96.56

5.3

4.7

4.65

4.69

mmol/l

3.60

11102

101843

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

12763

119976

2.26

94.86

11.9

11.1

24.88

24.92

u/l

0.04

12284

115069

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

12017

110825

1.79

92.47

5.2

4.7

1.50

1.52

mmol/l

2.55

10931

100361

(3009542) Hematocrit [Volume Fraction] of Blood

12986

123223

2.58

90.21

24.9

23.0

39.63

0.00

11988

114212

(3000963) Hemoglobin [Mass/volume] in Blood

12991

123360

2.58

88.87

25.0

23.0

133.35

133.12

g/l

1.08

12818

121265

(3024731) MCV [Entitic volume]

12989

123337

2.57

88.77

24.8

22.8

91.57

91.48

1.43

12810

121216

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

6311

51217

1.44

88.70

2.1

2.0

97.25

96.06

pmol/l

1.03

3015

25414

(3026361) Erythrocytes [#/volume] in Blood

12989

123344

2.57

88.63

24.9

22.9

4.41

e12/l

0.58

12604

119202

(3020564) Creatinine [Moles/volume] in Serum or Plasma

12729

119865

2.16

88.60

19.8

18.3

77.84

76.92

umol/l

2.44

12724

119829

(3010813) Leukocytes [#/volume] in Blood

12987

123338

2.56

88.20

24.9

22.9

6.68

6.70

e9/l

0.23

12598

119197

(3007461) Platelets [#/volume] in Blood

12983

123297

2.55

87.92

24.9

22.9

248.95

251.72

e9/l

5.35

12650

119600

(3035941) MCH [Entitic mass]

12984

123328

2.54

87.58

24.8

22.8

30.42

30.34

6.14

12805

121207

(3031040) Bacteria [#/volume] in Urine by Automated count

8981

77941

1.46

86.69

5.3

4.7

927.22

1852.60

e6/l

1.46

107

1083

(3001122) Ferritin [Mass/volume] in Serum or Plasma

5683

45563

1.43

83.62

3.0

2.8

126.29

143.22

ug/l

3.72

5146

41549

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

11638

107014

1.65

82.51

4.6

4.2

1.30

1.29

mmol/l

1.93

10467

95928

(40761511) CBC panel - Blood by Automated count

12373

115816

1.86

80.93

16.1

14.7

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

6961

58316

1.40

77.26

2.6

2.4

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

7990

69118

1.38

69.68

4.6

6.67

6.79

mmol/l

5.72

7567

64940

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

8009

69349

1.38

69.18

3.2

3.1

47.51

51.44

u/l

3.30

7304

63470

(40768804) Tissue Pathology biopsy report

5889

48529

1.38

69.05

2.3

2.1

—

(3009261) Glucose [Presence] in Urine by Test strip

6772

57238

1.37

66.99

4.4

3.9

0.00

estimate

0.15

1152

10357

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

6023

50088

1.37

65.41

2.3

2.2

81.17

79.84

nmol/l

3.15

5284

44105

(3035350) Ketones [Presence] in Urine by Test strip

6678

56451

1.36

65.30

4.3

3.9

0.00

estimate

0.44

1268

11342

(3021601) Nitrite [Presence] in Urine by Test strip

6687

56605

1.36

64.46

5.9

5.2

0.00

estimate

0.23

1170

10478

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

7286

62593

1.36

63.36

6.4

6.6

1.22

mmol/l

4.00

6197

52744

(3024561) Albumin [Mass/volume] in Serum or Plasma

6315

53238

1.35

61.23

4.4

4.7

35.55

35.05

g/l

10.85

5790

49205

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

3048

22878

1.43

59.92

1.3

1.2

1.30

1.76

u/ml

1.95

764

5829

(3015736) pH of Urine

5445

45101

1.35

58.29

4.0

3.6

5.82

5.83

0.09

335

2473

(3044889) 12 lead EKG panel

9232

82815

1.37

57.69

4.4

4.0

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

7263

62842

1.34

57.67

5.4

6.3

11.06

11.34

umol/l

1.05

6852

59570

(40768797) Stomach Pathology biopsy report

2321

16692

1.47

56.89

1.3

1.2

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

4616

37412

1.36

56.47

2.5

63.79

62.43

u/l

0.13

4206

34262

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

11536

107702

1.50

56.36

15.7

14.7

75.27

76.06

ml/min/173m2

4.37

9643

89029

(3013115) Eosinophils [#/volume] in Blood

6833

58714

1.33

56.26

5.6

5.9

0.19

e9/l

1.03

5926

50820

(3001604) Monocytes [#/volume] in Blood

6628

56703

1.33

56.24

5.5

5.7

0.58

0.59

e9/l

2.43

5656

48423

(3006315) Basophils [#/volume] in Blood

6636

56857

1.33

55.36

5.5

5.7

0.04

e9/l

0.23

5657

48535

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

6627

56815

1.33

54.82

5.7

5.8

1.22

mmol/l

3.19

5998

51312

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

2606

19286

1.44

54.63

1.3

36.14

38.20

iu/ml

0.20

854

6218

(3019198) Lymphocytes [#/volume] in Blood

6753

58075

1.33

54.55

5.5

5.8

1.93

1.90

e9/l

0.32

5900

50706

(40760892) CBC W Ordered Manual Differential panel - Blood

6255

53338

1.32

53.02

6.0

6.3

—

(3026493) Urate [Moles/volume] in Serum or Plasma

3861

30670

1.36

52.94

2.6

2.7

5770.61

5307.34

umol/l

0.24

3289

26299

(3022217) INR in Platelet poor plasma by Coagulation assay

6692

57699

1.32

52.01

16.3

16.0

1.25

1.30

inr

2.24

1893

16206

(3048689) Calprotectin [Mass/mass] in Stool

1770

12257

1.51

51.85

1.9

2.0

125.60

143.99

ug/g

1.35

1354

9506

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

2483

18367

1.43

51.84

1.3

13.31

14.61

u/ml

0.24

883

6679

(3018010) Neutrophils/100 leukocytes in Blood

6280

53712

1.32

51.52

5.6

5.9

56.84

57.74

7.53

5808

49942

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

4554

37212

1.34

51.47

2.2

2.1

163.46

204.97

u/l

3.28

4232

34620

(3013650) Neutrophils [#/volume] in Blood by Automated count

7587

66644

1.32

51.22

7.8

9.2

4.08

4.14

e9/l

1.00

6570

57783

(3019069) Monocytes/100 leukocytes in Blood

6243

53492

1.31

49.94

6.0

6.3

8.65

0.02

5775

49679

(3002030) Lymphocytes/100 leukocytes in Blood

6349

54552

1.31

49.64

5.8

6.1

28.17

27.20

9.72

5893

50756

(3006504) Eosinophils/100 leukocytes in Blood

6203

53202

1.31

48.83

5.7

6.0

2.89

2.84

1.06

5734

49327

(3002385) Erythrocyte distribution width [Ratio]

10397

95904

1.37

48.47

19.3

18.3

15.36

15.32

0.31

10222

94142

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

4561

37643

1.32

46.90

3.0

1210.26

1454.07

ng/l

4.59

3893

32493

(3009508) Creatinine [Moles/volume] in Urine

4578

37893

1.32

45.81

3.1

6.94

mmol/l

0.02

3776

31374

(3022096) Basophils/100 leukocytes in Blood

6004

51598

1.30

45.20

5.7

6.0

0.69

0.68

1.22

5535

47749

(3020682) Albumin/Creatinine [Ratio] in Urine

4696

39130

1.31

44.36

3.8

3.7

8.19

8.47

mg/mmol

0.10

2809

23590

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

3681

29648

1.33

44.33

2.4

2.3

2.83

3.08

mg/l

8.61

3125

25149

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

3896

31676

1.32

43.83

1.8

1.6

1.38

1.34

mmol/l

2.99

3210

26079

(3021960) Folate [Moles/volume] in Serum or Plasma

3633

29327

1.33

42.75

1.6

1.5

21.65

20.71

nmol/l

1.62

3030

24615

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

3126

24754

1.34

41.79

1.7

1.17

1.35

mg/l

1.52

2406

19237

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

161

506

3.21

40.69

1.1

7.10

7.81

nmol/l

0.06

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

5424

46420

1.28

40.61

4.0

3.7

60.92

53.18

ng/l

0.21

3882

33747

(3026008) Bacteria identified in Urine by Culture

4794

40422

1.29

40.27

3.6

3.3

—

(3012516) Albumin [Mass/volume] in Urine

4450

37188

1.29

39.98

3.2

361.93

422.44

mg/l

0.37

2641

22671

(3018418) pH of Serum or Plasma

4458

37398

1.29

38.48

3.8

4.1

7.40

1.03

746

7167

(3018095) Leukocytes [#/volume] in Urine

4894

41603

1.28

37.83

4.0

3.7

89.80

115.21

e6/l

1.32

3500

29363

(3000494) Fungus identified in Specimen by Culture

1806

13279

1.42

37.77

1.4

—

(3019309) Folate [Moles/volume] in Red Blood Cells

3028

24201

1.32

37.27

1.8

1161.67

1173.20

nmol/l

0.27

2274

17934

(3022145) Colonoscopy Study observation

1797

13248

1.41

36.95

1.3

—

(3007164) IgA [Mass/volume] in Serum or Plasma

2536

19793

1.35

36.64

1.4

1.5

2.34

2.52

g/l

3.66

1413

11267

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

6214

54644

1.26

35.22

2.6

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

3360

27482

1.30

34.43

4.1

3.8

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

4258

35945

1.27

33.79

3.0

3.2

33.37

34.94

u/l

0.43

4007

33900

(3015377) Calcium [Moles/volume] in Serum or Plasma

4949

42589

1.26

33.19

3.1

3.5

2.36

mmol/l

0.95

4215

36894

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

4995

43039

1.26

33.11

4.7

4.2

—

(3007853) Bacteria identified in Skin by Aerobe culture

1729

13102

1.37

29.63

1.7

1.8

—

(4200892) Spirometry reversibility

1221

8739

1.44

29.23

1.5

1.4

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

751

4863

1.58

29.21

1.1

—

(3030467) Casts [#/volume] in Urine by Automated count

3911

33117

1.26

29.20

3.4

3.2

0.36

0.48

e6/l

3.02

2988

25169

(3037522) Nuclear Ab [Titer] in Serum

1896

14648

1.34

28.56

1.3

490.10

548.53

titre

0.73

404

3316

(3002582) Erythrocytes [#/volume] in Urine

4183

35823

1.24

27.95

3.5

3.3

77.78

85.50

e6/l

0.10

3208

27298

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

3198

26565

1.27

27.88

1.8

1.7

26747804.80

33558301.90

pmol/l

0.33

2561

21527

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

3429

28738

1.26

27.69

5.9

5.4

2.88

3.37

ug/l

0.90

3050

25515

(36660697) Celiac disease serology panel - Serum

1159

8307

1.43

27.47

1.2

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1797

13880

1.34

26.99

1.4

1.3

—

(3026782) Osmolality of Urine

2891

23844

1.27

26.53

3.3

3.0

525.65

526.55

mosm/kgh2o

0.08

2472

20383

(3003338) MCHC [Mass/volume]

9698

90894

1.24

26.09

22.2

20.4

331.59

331.05

g/l

7.64

9635

90205

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

2526

20536

1.28

25.97

3.0

2.8

1.08

1.38

e6/l

1.20

1440

11729

(1002224) Polysomnography panel

539

3339

1.64

25.18

1.1

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

2875

23847

1.26

24.91

4.2

3.8

207.23

444.13

ng/l

4.70

2323

19412

(3025941) Bacteria identified in Stool by Culture

855

5895

1.48

24.78

1.3

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

758

5102

1.51

24.71

2.2

2.1

12.55

11.82

nmol/l

1.64

653

4436

(3003327) Ova and parasites identified in Stool by Light microscopy

528

3281

1.63

24.37

1.6

1.7

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

1084

7857

1.41

24.03

1.2

—

(36304419) Bacteria [Presence] in Urine

3730

31973

1.23

23.82

3.3

3.1

—

(3000850) Epithelial cells [#/volume] in Urine

2980

24998

1.25

23.13

2.6

5.44

5.99

e6/l

1.57

2665

22328

(3044640) Blood type and Crossmatch panel - Blood

4326

37826

1.21

22.33

2.3

2.5

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

2857

23953

1.24

22.13

2.8

3.1

2.45

2.47

mmol/l

5.35

2465

20971

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

2308

18883

1.27

22.11

3.2

3.0

3.13

3.10

e6/l

0.04

1226

10185

(3041096) Erythrocytes [Presence] in Urine by Automated

3420

29239

1.23

22.05

4.1

3.7

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

273

1449

1.90

21.85

1.7

1.5

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

949

6838

1.42

21.71

2.5

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

1292

9818

1.35

21.35

3.6

88.09

90.91

ng/l

0.55

1092

8332

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1322

10082

1.35

21.33

2.2

371.34

380.01

nmol/l

0.86

1217

9210

(3021589) Normoblasts [#/volume] in Blood

5616

50491

1.19

21.09

9.7

10.0

0.01

0.00

e9/l

0.43

4571

41203

(3013512) EKG study

4214

36985

1.20

20.45

4.5

4.1

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

2734

22988

1.24

20.38

5.1

4.6

22.52

22.00

1.02

1465

12172

(3019150) Specific gravity of Urine by Refractometry

2915

24681

1.23

20.35

4.7

4.4

1.02

kg/l

1.20

426

3904

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1419

11074

1.31

19.44

1.5

—

(3000492) Spirometry study

1273

9795

1.33

19.26

1.6

1.5

—

(3029937) Albumin [Presence] in Urine by Test strip

3552

30844

1.21

19.01

4.8

4.3

0.00

estimate

0.31

1142

10164

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

580

3904

1.51

18.91

1.8

1.5

—

(3033658) Prothrombin time (PT) actual/Normal

3463

30012

1.21

18.90

3.8

3.9

90.78

89.77

1.49

3373

29266

(3000570) Elastase.pancreatic [Mass/mass] in Stool

542

3618

1.52

18.39

1.4

281.86

268.92

ug/g

0.81

314

2171

(3022948) Iron [Moles/volume] in Serum or Plasma

2259

18804

1.24

18.23

2.5

12.82

12.37

umol/l

2.18

2065

17405

(3049717) Cytology report of Urine Cyto stain

661

4602

1.46

18.21

2.7

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

389

2413

1.63

18.16

1.2

1.1

—

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

135

3.86

17.79

1.1

1.0

—

(40768443) Skin Pathology biopsy report

758

5472

1.41

17.12

1.2

—

(3005322) IgE [Units/volume] in Serum or Plasma

838

6154

1.39

17.11

1.3

133.02

216.99

u/ml

5.33

751

5605

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

311

1851

1.70

17.05

1.8

1.5

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

1388

11013

1.29

16.68

3.1

2.8

179.35

209.70

ng/l

1.94

1257

10110

(3002256) Pathology report gross observation

1921

15897

1.24

16.18

1.3

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

607

4255

1.45

16.15

1.2

0.24

0.99

u/ml

5.12

402

(3004789) Transferrin [Mass/volume] in Serum or Plasma

2085

17454

1.23

15.74

2.5

2.33

2.31

g/l

0.85

1894

16053

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

509

3469

1.49

15.66

1.8

1.5

—

(3042936) Bacteria identified in Isolate by Culture

1968

16385

1.24

15.64

1.9

2.0

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

2084

17480

1.23

15.41

1.4

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

396

2570

1.56

15.33

1.4

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1960

16416

1.23

14.64

3.5

3.2

0.79

ug/l

0.05

1431

11715

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

876

6657

1.34

14.36

1.3

42.05

58.08

au/ml

1.66

352

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1961

16457

1.22

14.34

2.5

2.6

21.96

21.65

0.42

1604

13933

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

459

3123

1.49

14.27

1.2

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

953

7365

1.32

13.89

2.5

2.4

23.14

25.73

au/ml

0.29

491

(40758558) Short blood count panel - Blood

3350

29628

1.17

13.66

5.8

7.0

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

459

3157

1.47

13.53

1.2

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1330

10779

1.26

13.34

2.6

2.4

33.68

51.75

u/l

1.50

1124

9146

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1865

15680

1.22

13.32

5.1

5.4

1.03

1.04

mmol/l

0.50

1712

14496

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1527

12589

1.24

13.15

3.5

—

(42529406) Shigella sp [Presence] in Stool by Culture

458

3167

1.46

13.14

1.2

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

251

1520

1.66

13.01

1.5

1.7

45.26

45.21

nmol/l

0.01

245

1448

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1134

9055

1.28

12.87

1.7

1.6

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

3254

28894

1.17

12.41

2.3

2.4

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

886

6946

1.29

11.62

3.0

3.2

4.36

4.39

pmol/l

0.39

780

6084

(3004716) Salmonella sp identified in Stool by Organism specific culture

614

4581

1.36

11.40

1.3

1.4

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

187

1098

1.71

10.95

1.8

205.42

192.70

pmol/l

0.85

170

1019

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

429

3038

1.43

10.90

1.2

47.43

37.69

u/ml

0.21

180

(3027945) Reticulocytes/100 erythrocytes in Blood

1647

13938

1.21

10.88

2.2

2.4

1.74

1.81

2.27

1440

12230

(3007930) Methemoglobin/Hemoglobin.total in Blood

672

5129

1.33

10.73

5.2

5.0

0.88

0.04

637

4793

(3001019) Free T4 and TSH panel - Serum or Plasma

527

3881

1.37

10.65

1.8

—

(3023520) Reticulocytes [#/volume] in Blood

1281

10608

1.23

10.51

2.4

2.5

67.11

69.75

e9/l

2.03

969

8073

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

2266

19801

1.17

10.34

1.9

1.8

—

(3008898) HLA-B27 [Presence]

376

2626

1.44

10.33

1.0

1.1

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

2120

18433

1.18

10.28

1.9

2.0

29.69

29.79

0.33

2054

17894

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

677

5207

1.32

10.25

5.1

5.0

1.63

1.61

0.24

642

4867

(3012544) pH of Venous blood

1372

11478

1.22

10.18

3.8

3.7

7.39

7.38

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

232

1469

1.59

10.15

1.3

275.95

310.76

pmol/l

0.79

204

1266

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

577

4346

1.34

10.10

1.1

1.18

5.53

u/ml

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

112

577

1.95

10.07

1.1

6.05

8.83

iu/ml

0.91

126

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

732

5708

1.30

10.02

1.3

—

(1761868) Lipid panel - Serum or Plasma

3888

35400

1.14

10.00

3.5

3.1

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

380

2685

1.43

9.82

1.1

2.78

10.82

u/ml

3.69

244

(3011985) Renin [Units/volume] in Plasma

243

1573

1.55

9.69

1.3

1.4

47.44

60.04

mu/l

0.66

215

1394

(3047181) Lactate [Moles/volume] in Blood

516

3851

1.35

9.62

6.0

5.8

1.27

1.32

mmol/l

0.71

465

3381

(3045424) Erythrocytes [Presence] in Urine

293

1978

1.49

9.61

1.5

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

833

6642

1.27

9.57

1.2

117.27

145.06

iu/ml

1.52

285

2472

(3009343) pH of Capillary blood

925

7475

1.26

9.49

3.4

3.5

7.41

7.42

2.13

114

1010

(3004119) Hemoglobin [Mass/volume] in Venous blood

907

7323

1.26

9.38

3.6

3.3

128.59

126.89

g/l

1.59

888

7142

(40761535) Cells panel - Urine sediment

1211

10093

1.22

9.32

3.9

3.5

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

934

7576

1.25

9.27

3.5

5.18

5.17

kpa

0.24

882

7162

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

367

0.14

9.24

9.0

10.6

656.20

845.44

nmol/l

—

348

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

393

2831

1.40

9.13

1.2

1.3

5.09

6.73

u/ml

0.28

476

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

595

4573

1.32

9.09

1.8

38.76

39.25

u/l

0.23

514

3934

(3022313) Gas panel - Capillary blood

682

5341

1.29

9.06

3.6

3.7

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

890

7201

1.25

9.04

3.4

3.5

1.65

2.01

mmol/l

2.45

670

5473

(46235355) HIV 1 and 2 tests - Meaningful Use set

1305

11014

1.20

8.82

1.6

1.5

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

309

2147

1.45

8.79

1.2

32.80

46.49

u/ml

0.81

233

(3003396) Base excess in Arterial blood by calculation

1633

14069

1.18

8.76

6.2

6.8

1.36

1.16

mmol/l

1.48

1371

11306

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

386

2797

1.39

8.68

1.2

1.3

13.14

4.21

u/ml

0.48

299

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

385

0.18

8.48

8.6

15.5

1060.57

1478.75

nmol/l

—

369

(3002032) Base excess in Venous blood by calculation

1303

11051

1.20

8.35

3.7

3.8

2.13

1.99

mmol/l

0.79

1134

9444

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1572

13593

1.18

8.05

1.8

1.7

—

(3018572) Chloride [Moles/volume] in Blood

375

2745

1.38

7.97

6.9

6.7

105.04

105.03

mmol/l

0.01

342

2447

(3039000) Anion gap in Blood

375

2745

1.38

7.97

6.9

6.7

10.67

11.16

mmol/l

2.83

342

2447

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

592

4634

1.29

7.93

3.9

24.82

25.08

mmol/l

1.44

541

4251

(3023323) Follitropin [Units/volume] in Serum or Plasma

410

3048

1.36

7.91

1.3

36.94

39.64

iu/l

0.85

365

2642

(3023368) Bacteria identified in Blood by Culture

3595

32961

1.12

7.89

4.2

4.3

—

(3004588) Protein electrophoresis panel - Serum or Plasma

1057

8846

1.21

7.80

2.2

2.4

—

(3016502) Oxygen saturation in Arterial blood

1463

12610

1.18

7.78

6.5

7.1

95.65

95.55

0.28

1408

12115

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1270

10819

1.19

7.74

2.4

2.3

5.52

6.89

ug/l

1.90

1080

9338

(3019060) Gas panel - Arterial blood

986

8209

1.22

7.68

4.8

4.6

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1296

11074

1.19

7.63

3.7

3.8

5.86

5.81

kpa

1.00

1266

10753

(3025018) Bordetella pertussis Ab [Titer] in Serum

518

1.86

7.62

1.2

1.3

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1621

14112

1.17

7.62

6.3

6.8

5.19

5.09

kpa

4.13

1548

13446

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

626

4962

1.27

7.60

1.9

2.3

—

(3027801) Oxygen [Partial pressure] in Arterial blood

1620

14105

1.17

7.60

6.2

6.8

11.90

12.27

kpa

2.24

1546

13430

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

441

3338

1.33

7.56

1.5

1.7

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

626

4966

1.27

7.56

1.9

2.3

7.40

7.51

g/l

0.86

549

4421

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

624

4951

1.27

7.52

1.9

2.3

3.63

3.72

g/l

0.53

549

4413

(3047007) Chlamydophila sp Ab [Presence] in Serum

196

1286

1.53

7.47

1.2

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

2241

20012

1.14

7.43

2.8

3.2

0.82

0.81

mmol/l

0.62

2071

18589

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

207

1376

1.51

7.42

1.1

3.15

10.18

au/ml

—

(3020630) Protein [Mass/volume] in Serum or Plasma

1245

10627

1.19

7.42

2.3

2.7

66.09

66.15

g/l

0.11

1108

9535

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

109

618

1.77

7.38

1.5

1.4

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1348

11597

1.18

7.33

6.9

7.6

121.41

119.50

g/l

2.94

1307

11263

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

587

4639

1.28

7.32

1.9

2.4

2.92

2.97

g/l

0.61

513

4097

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1550

13492

1.17

7.29

2.4

2.6

7.63

8.65

umol/l

1.03

1343

11701

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

328

2387

1.38

7.26

1.2

3.97

5.44

u/ml

0.24

190

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

805

6607

1.23

7.22

8.0

9.2

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

584

4621

1.28

7.21

1.9

2.3

9.55

10.12

g/l

3.39

506

4043

(3024354) Oxygen [Partial pressure] in Venous blood

1078

9108

1.20

7.20

3.2

3.1

4.48

4.52

kpa

0.25

1050

8812

(3020961) Endomysium IgA Ab [Titer] in Serum

585

4631

1.28

7.20

1.1

224.09

199.56

titre

0.07

109

(3026389) Candida sp identified in Specimen by Organism specific culture

246

1705

1.45

7.18

1.4

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

198

1317

1.51

7.10

1.1

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

753

6148

1.24

7.10

3.1

2.7

0.18

0.31

e6/l

5.49

726

5999

(3045414) Leukocytes [Presence] in Urine

669

5409

1.25

6.90

1.9

—

(3016038) Potassium [Moles/volume] in Urine

137

844

1.63

6.87

1.1

1.2

33.85

34.59

mmol/l

0.16

112

706

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

511

4012

1.28

6.74

1.6

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

491

3838

1.29

6.71

1.9

2.2

37.97

37.40

g/l

1.36

414

3283

(3019225) pH of Specimen

1503

13143

1.16

6.65

4.3

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

529

4191

1.27

6.50

2.0

2.5

0.48

1.00

g/l

5.56

447

3542

(3017315) Amylase [Enzymatic activity/volume] in Urine

103

599

1.73

6.45

1.1

1.2

220.13

278.43

u/l

0.38

546

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

126

776

1.63

6.36

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

126

776

1.63

6.36

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

126

776

1.63

6.36

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

125

769

1.63

6.34

1.1

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

219

1524

1.44

6.32

1.2

1.3

13.58

15.39

u/l

0.93

167

1219

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

125

770

1.63

6.31

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

125

771

1.63

6.28

1.1

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

393

3019

1.31

6.15

1.6

1.5

39.42

9.39

iu/ml

0.47

694

(3008152) Bicarbonate [Moles/volume] in Arterial blood

915

7730

1.20

6.15

7.2

6.8

25.04

24.71

mmol/l

2.27

870

7342

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

416

3222

1.30

6.13

1.5

0.23

0.24

g/l

0.11

395

3026

(3024891) Influenza virus A+B Ag [Presence] in Specimen

323

2418

1.34

6.06

1.2

—

(3003181) Sodium [Moles/volume] in Urine

313

2332

1.35

6.06

1.3

1.4

58.68

62.27

mmol/l

1.05

260

1844

(3014111) Lactate [Moles/volume] in Serum or Plasma

1211

10494

1.17

6.03

5.5

6.6

1.27

1.35

mmol/l

2.45

1185

10216

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1541

13601

1.15

6.00

1.8

—

(3000475) Leukocytes [#/volume] in Synovial fluid

394

3040

1.30

5.98

1.6

10342.92

14345.84

e6/l

1.15

288

2163

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1594

14108

1.15

5.96

3.6

4.2

236.72

248.40

u/l

3.00

1506

13269

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

433

3390

1.29

5.89

1.9

2.3

0.00

g/l

0.37

390

3052

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

425

3321

1.29

5.87

1.5

1.20

1.19

g/l

0.70

404

3130

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

376

2894

1.31

5.83

1.9

11.09

11.67

mg/l

0.66

347

2653

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

687

5679

1.22

5.81

1.5

1.7

1.53

1.61

g/l

1.32

596

4817

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

340

2582

1.33

5.80

2.0

1.5

5.11

17.19

iu/l

0.64

107

830

(3010838) Calcium [Moles/time] in 24 hour Urine

303

2266

1.34

5.74

1.7

1.8

5.44

4.93

mmol/24h

0.71

254

1978

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

315

2370

1.34

5.73

1.5

1.6

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

478

1.76

5.72

1.6

8.17

3.83

nmol/l

0.41

395

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

102

613

1.67

5.71

1.8

1.9

16.37

15.51

nmol/l

0.59

569

(3044941) Cell count panel - Synovial fluid

262

1922

1.37

5.63

1.5

1.4

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1760

15741

1.14

5.62

5.2

4.8

33.33

33.20

0.20

1189

10299

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

261

2.03

5.60

1.1

1.3

105.80

134.42

nmol/l

0.76

182

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

458

3639

1.27

5.56

1.9

2.3

0.02

0.04

g/l

0.64

415

3289

(3027273) Bicarbonate [Moles/volume] in Venous blood

714

5962

1.21

5.47

3.5

3.4

25.65

25.28

mmol/l

2.57

697

5783

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

423

3337

1.28

5.45

1.9

2.4

0.00

g/l

-0.00

387

3040

(4094501) Cardiovascular stress test using bicycle ergometer

404

3175

1.28

5.37

1.1

—

(3052851) Hemolysis interference index of Serum or Plasma

463

3700

1.26

5.37

3.0

3.3

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

417

3292

1.28

5.35

1.4

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

199

1408

1.42

5.32

1.2

68.59

61.51

u/ml

—

110

(3022621) pH of Urine by Test strip

930

7979

1.18

5.26

3.4

3.2

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

482

3889

1.25

5.15

1.4

1.6

223.00

252.28

titre

0.08

195

(3000991) Gas panel - Venous blood

1147

10021

1.16

5.15

6.6

7.8

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

347

2691

1.30

5.14

1.3

1.4

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

660

5505

1.21

5.13

4.1

4.0

46.39

47.91

0.89

655

5444

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

330

2549

1.30

5.04

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

330

2549

1.30

5.04

1.3

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

293

1.92

5.03

1.3

1.2

113.90

113.16

0.07

257

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1122

9807

1.16

5.01

1.6

1.46

1.48

0.58

938

8320

(3021387) Prolactin [Units/volume] in Serum or Plasma

230

1690

1.37

4.95

1.7

1.8

315.80

334.18

mu/l

0.21

216

1541

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

316

1.87

4.95

1.3

1.2

0.29

0.31

g/l

0.76

259

(1761482) Bacteria [#/volume] in Urine by Culture

425

3402

1.26

4.89

6.2

4.4

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

340

2652

1.29

4.84

1.6

1.7

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

173

1216

1.43

4.84

1.1

1.26

1.53

u/ml

0.26

568

(40761536) Microorganisms panel - Urine sediment

1110

9769

1.15

4.53

4.6

4.2

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

605

5073

1.20

4.49

1.4

1.5

4.10

18.02

u/ml

5.61

121

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

231

1730

1.34

4.44

1.2

1.3

0.24

0.26

nmol/l

—

145

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

1091

9615

1.15

4.37

2.6

2.7

62.57

62.32

ml/min/173m2

0.08

472

3909

(3020779) Urea [Moles/volume] in Serum or Plasma

1196

10608

1.14

4.36

6.4

6.8

9.85

10.28

mmol/l

1.32

1131

10066

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

204

1505

1.36

4.34

1.2

1.3

—

nmol/l

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

229

1720

1.34

4.33

1.2

1.3

0.62

2.19

nmol/l

1.03

219

1645

(3019832) Treponema pallidum Ab [Presence] in Serum

400

3231

1.25

4.30

1.5

1.4

—

(3017732) Neutrophils [#/volume] in Blood

905

7880

1.16

4.29

2.8

3.1

4.61

5.02

e9/l

0.39

676

6065

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

515

4274

1.21

4.28

2.7

2.6

—

(3038515) Glucose [Moles/volume] in Venous blood

335

2656

1.27

4.24

3.6

3.4

7.29

7.60

mmol/l

1.53

330

2597

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

628

1.55

4.13

1.6

1.5

5.27

6.33

u/l

1.46

524

(3008037) Lactate [Moles/volume] in Venous blood

349

2791

1.26

4.12

3.6

3.3

1.51

1.60

mmol/l

1.41

343

2726

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

215

1615

1.34

4.09

2.1

2.0

21.10

27.70

mg/l

1.12

423

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

165

1189

1.39

4.08

3.4

3.7

—

(3008295) Osmolality of Serum or Plasma

166

1198

1.39

4.07

1.3

276.91

276.45

mosm/kgh2o

0.10

132

913

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1205

10749

1.13

4.03

3.3

3.8

1.23

mmol/l

0.57

1025

9322

(4034850) Laboratory test

460

3801

1.22

4.02

10.5

10.2

—

(3005719) IgG [Mass/volume] in Serum or Plasma

938

8237

1.15

3.98

2.7

2.8

10.21

10.45

g/l

0.84

844

7544

(3028026) IgM [Mass/volume] in Serum or Plasma

753

6506

1.17

3.98

1.8

1.9

1.24

1.37

g/l

0.75

674

5855

(3033705) Calcium.ionized [Moles/volume] in Venous blood

211

1593

1.33

3.90

2.6

2.4

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

149

1065

1.40

3.88

1.1

4.81

2.74

u/ml

0.66

457

(3008401) Mugwort IgE Ab [Units/volume] in Serum

145

1034

1.41

3.83

1.1

0.75

0.99

u/ml

0.26

396

(3017143) Hepatitis C virus Ab [Presence] in Serum

1062

9435

1.14

3.80

1.5

—

(3037121) Protein [Mass/volume] in Urine

493

4128

1.20

3.78

3.0

2.9

0.35

0.28

g/l

0.84

173

1613

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

436

3610

1.21

3.76

1.3

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

134

948

1.42

3.72

1.3

1.2

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

128

2.19

3.69

2.2

1.8

—

(3024928) Oxygen saturation in Venous blood

304

2432

1.26

3.63

3.7

3.1

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

528

1.56

3.63

1.1

1.2

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

108

740

1.46

3.57

1.1

1.0

1.98

2.60

u/ml

0.27

263

(3038177) Helicobacter pylori Ab [Presence] in Serum

206

1572

1.32

3.57

1.3

1.2

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

515

1.56

3.55

1.1

1.0

—

(3023419) Bacteria identified in Sputum by Culture

240

1873

1.29

3.52

2.4

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

205

1569

1.31

3.48

1.6

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

207

1588

1.31

3.46

1.2

1.3

—

(3021788) Differential panel - Synovial fluid

285

2278

1.26

3.45

1.5

—

(3000034) Microalbumin [Mass/volume] in Urine

156

1149

1.36

3.44

3.2

3.0

37.75

35.39

mg/l

0.07

110

819

(3014133) Dog dander IgE Ab [Units/volume] in Serum

113

789

1.44

3.40

1.1

1.0

5.67

2.52

u/ml

0.73

333

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

157

1160

1.36

3.40

2.6

3.0

—

(3000330) Specific gravity of Urine by Test strip

740

6473

1.15

3.36

4.9

3.7

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

847

7480

1.14

3.35

1.8

1.7

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

346

2835

1.23

3.35

2.1

2.2

126.79

126.88

g/l

0.02

245

2030

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

639

1.47

3.27

2.1

1.8

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

287

2313

1.25

3.25

2.4

3.0

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

730

6418

1.15

3.11

7.0

8.7

24.72

24.41

mmol/l

2.07

701

6212

(3002079) Sodium [Moles/time] in 24 hour Urine

477

1.53

3.08

1.2

151.97

153.83

mmol/24h

0.08

477

(3025130) Human papilloma virus identified in Specimen

162

1225

1.33

3.05

1.5

1.6

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

105

740

1.42

3.05

1.2

1.1

—

(3051611) Lipemic interference index of Serum or Plasma

177

1357

1.31

3.03

3.2

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

278

2253

1.24

3.02

1.2

3.80

3.78

mmol/l

0.12

260

2113

(3024980) IgG subclass 4 [Mass/volume] in Serum

209

1638

1.28

3.02

1.6

1.5

0.66

0.77

g/l

1.00

162

1226

(3014271) Vancomycin [Susceptibility]

692

1.43

3.01

2.8

3.0

—

(3016018) Differential panel - Cerebral spinal fluid

141

1047

1.35

3.00

1.3

1.4

—

(4281824) Cell count and differential, peritoneal fluid

125

1696

0.73

2.99

1.1

—

(3004616) Nuclear Ab [Presence] in Serum

185

1432

1.30

2.96

1.3

—

(21494755) Public health laboratory ask at order entry panel

677

5946

1.15

2.94

1.4

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

378

3170

1.20

2.94

1.6

1.7

2.49

3.69

mg/l

2.92

295

2368

(3018851) Theophylline [Moles/volume] in Serum or Plasma

114

2.11

2.93

1.5

1.7

42.63

44.71

umol/l

0.08

114

(3035637) Corticotropin [Mass/volume] in Plasma

177

1367

1.30

2.89

1.4

1.5

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

310

2558

1.22

2.86

1.3

526.27

546.39

mg/l

0.21

298

2414

(3044290) Cell count panel - Cerebral spinal fluid

255

2062

1.24

2.85

1.3

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

274

1.68

2.85

1.0

1.1

0.60

0.66

umol/24h

0.44

128

(3015235) Bicarbonate [Moles/volume] in Capillary blood

370

3108

1.20

2.84

2.5

3.0

25.03

mmol/l

0.01

363

3043

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

652

1.43

2.81

1.3

1.2

—

(1616796) Gas panel - Central venous blood

326

2709

1.21

2.81

2.8

3.7

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

287

0.38

2.78

2.2

2.4

95.91

155.69

nmol/l

2.15

252

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1109

10075

1.11

2.77

1.4

1.5

—

(44813793) Dust mix specific IgE antibody measurement

705

1.41

2.75

1.1

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

622

5462

1.15

2.74

4.0

4.1

24.40

24.24

mmol/l

0.65

608

5333

(3010726) Horse dander IgE Ab [Units/volume] in Serum

120

884

1.36

2.73

1.1

1.0

0.40

0.90

u/ml

1.91

409

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

588

5146

1.15

2.72

1.9

—

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

2.71

1.9

1.4

0.50

0.62

mg/l

—

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

2.71

1.9

1.4

0.11

2.12

mg/l

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

658

1.42

2.69

1.3

1.2

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

461

1.50

2.68

1.1

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

799

7143

1.13

2.67

5.3

6.6

25.31

24.87

mmol/l

3.14

790

7071

(4062490) Immunoglobulin typing, IgG

138

1044

1.33

2.64

1.5

1.4

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

140

1062

1.32

2.63

1.1

1.23

1.94

iu/ml

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

628

1.42

2.62

1.0

0.46

0.38

u/ml

0.07

174

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

231

1868

1.24

2.62

1.2

1.3

228.08

199.63

miu/ml

0.49

780

(3011648) Oxygen content in Venous blood

117

865

1.36

2.62

2.2

2.0

11.11

10.77

0.38

117

865

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

556

1.44

2.56

1.1

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

541

4729

1.15

2.56

1.9

1.8

—

(3011048) Pyruvate [Moles/volume] in Blood

3.06

2.56

1.1

1.3

81.55

88.80

umol/l

0.20

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

752

0.64

2.55

1.1

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

426

3663

1.17

2.52

1.3

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

156

1212

1.29

2.49

1.1

2.83

3.90

u/ml

0.44

453

(3038026) Centromere Ab [Units/volume] in Serum

129

977

1.32

2.48

1.2

19.92

51.88

u/ml

—

(3035320) C reactive protein [Mass/volume] in Body fluid

115

857

1.34

2.46

2.8

2.4

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

348

2950

1.18

2.46

1.5

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

225

1.69

2.45

1.8

1.6

7.86

9.33

mg/l

1.04

179

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

2.55

2.44

1.9

1.4

0.53

2.42

mg/l

—

(3002179) Metamyelocytes/100 leukocytes in Blood

1010

9204

1.11

2.41

3.7

3.9

0.92

0.72

0.59

288

3094

(3002523) Influenza virus A Ag [Presence] in Specimen

130

992

1.31

2.38

1.1

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1263

11641

1.09

2.38

2.0

2.1

0.22

0.21

g/l

5.27

1173

10855

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

2.35

2.38

1.1

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

125

949

1.32

2.38

1.2

69.29

33.24

u/ml

—

(3000012) Reticulocyte production index

225

1837

1.23

2.37

1.8

2.1

—

(3021901) Oxygen saturation in Capillary blood

273

2276

1.20

2.34

2.4

2.9

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

124

946

1.31

2.29

1.2

64.40

77.16

u/ml

—

(3003740) Influenza virus B Ag [Presence] in Specimen

129

994

1.30

2.23

1.1

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

152

1197

1.27

2.22

1.5

1.4

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

152

1197

1.27

2.22

1.5

1.4

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

266

2227

1.20

2.20

1.2

1.4

24.31

33.06

e6/l

0.24

200

1730

(3004451) EKG impression Narrative

651

1.37

2.19

1.3

1.2

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

266

2229

1.20

2.18

1.3

1.4

852.31

1249.03

e6/l

0.53

216

1828

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

450

1.45

2.18

1.2

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

401

1.47

2.17

1.2

1.3

135.54

182.46

pmol/l

1.14

401

(3024139) IgG subclass 3 [Mass/volume] in Serum

135

1051

1.29

2.17

1.5

1.4

0.40

0.42

g/l

0.32

735

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

483

4246

1.14

2.16

2.1

2.2

451.57

619.20

ug/l

0.66

448

3993

(3028192) IgG subclass 2 [Mass/volume] in Serum

135

1052

1.29

2.15

1.5

1.4

2.91

2.86

g/l

0.11

736

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

305

1.54

2.15

1.4

1.3

37.24

35.74

0.09

196

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

3.00

2.14

1.0

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

674

6055

1.12

2.13

1.3

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

754

6816

1.11

2.13

1.9

1.8

—

(3051651) Icteric interference index of Serum or Plasma

714

1.35

2.13

3.6

3.7

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

274

1.57

2.13

8.7

8.0

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

2.10

2.12

4.1

4.5

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

192

1564

1.23

2.11

1.4

1.6

58.24

58.18

0.01

108

955

(40767503) Oxygen content in Capillary blood by calculation

312

2661

1.18

2.10

2.3

2.5

15.61

15.91

0.72

164

1385

(3019420) Tryptase [Mass/volume] in Serum or Plasma

512

1.41

2.10

1.8

1.6

12.80

9.03

ug/l

0.61

464

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

2.00

2.10

1.0

0.03

0.54

u/ml

1.03

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

118

907

1.30

2.10

1.2

2.00

4.65

u/ml

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

692

1.35

2.07

1.4

1.3

1.40

1.20

promille

0.65

514

(3038071) Oxygen [Partial pressure] in Mixed venous blood

237

1.61

2.06

8.5

7.6

—

(1617658) Protocol used for examination of sentinel lymph nodes

1191

0.75

2.06

1.1

1.0

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

245

1.59

2.06

1.4

1.3

—

(3021440) Promyelocytes/100 leukocytes in Blood

1046

9631

1.09

2.05

3.9

4.0

0.12

0.06

279

3103

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

117

1.88

2.05

1.2

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

134

1052

1.28

2.04

1.5

1.4

6.70

6.80

g/l

0.11

731

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

358

1.48

2.03

1.3

1.2

—

(3016879) Cocaine [Presence] in Urine

138

1088

1.27

2.03

1.4

1.6

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

118

1.87

2.01

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

118

1.87

2.01

1.2

—

(3028626) Oxygen [Partial pressure] in Capillary blood

310

2655

1.17

2.00

2.5

2.8

8.07

7.98

kpa

0.50

302

2597

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

2.63

2.00

1.5

—

(3045716) Anion gap in Serum or Plasma

543

1.38

1.99

2.4

2.6

9.60

9.73

mmol/l

0.12

531

(3019230) Fractional oxyhemoglobin in Venous blood

232

1940

1.20

1.98

3.2

2.9

62.67

63.56

0.26

232

1933

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

138

1092

1.27

1.98

1.1

—

(3000093) Morphology [Interpretation] in Blood Narrative

144

1146

1.26

1.97

1.1

—

(3014007) Fractional oxyhemoglobin in Arterial blood

844

7712

1.10

1.96

7.5

8.5

93.90

93.85

0.11

844

7683

(3025159) Blasts/100 leukocytes in Blood

987

9087

1.09

1.95

3.9

4.0

0.05

0.42

3.65

231

2604

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

205

1697

1.21

1.95

1.2

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

478

1.40

1.94

1.0

1.1

5.32

4.67

u/ml

0.10

(3011288) Drugs identified in Urine by Screen method

752

1.32

1.94

1.6

2.1

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

4.55

1.94

6.2

1.0

2.94

1.57

mu/l

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

256

2167

1.18

1.92

1.2

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

290

1.52

1.91

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

290

1.52

1.91

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

290

1.52

1.91

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

290

1.52

1.91

1.1

—

(3017181) Myelocytes/100 leukocytes in Blood

1096

10148

1.09

1.91

3.8

4.0

1.18

0.99

0.79

331

3599

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

311

2679

1.16

1.89

1.5

1.6

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

128

1.80

1.89

1.0

1.1

1.68

1.70

umol/24h

0.03

128

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

166

1.69

1.86

1.1

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

189

1.64

1.86

8.7

6.4

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

260

1.54

1.85

1.1

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

260

1.54

1.85

1.4

1.5

105.09

115.18

ng/l

0.20

260

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

4.17

1.82

1.0

1.1

—

(3007733) Chloride [Moles/volume] in Urine

3.04

1.79

1.1

102.43

82.89

mmol/l

—

(3014051) Protein [Presence] in Urine by Test strip

373

3275

1.14

1.77

2.7

2.6

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1690

15965

1.07

1.74

7.6

7.3

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

2.22

1.73

1.0

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

3.85

1.71

1.0

1.1

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

0.00

1.70

0.0

8.3

—

(3020650) Glucose [Presence] in Urine

242

1.53

1.69

1.4

1.5

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

323

2820

1.15

1.68

2.8

1.54

1.66

mg/l

1.83

289

2547

(3024263) Appearance of Synovial fluid

639

1.32

1.67

1.5

1.4

—

(3006462) Nitrate [Presence] in Urine

579

1.33

1.66

3.8

3.5

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

400

1.40

1.66

1.2

1.1

—

(3027008) Opiates [Presence] in Urine

146

1191

1.23

1.66

1.4

1.5

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

134

1.72

1.65

1.0

1.1

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

1.97

1.64

1.6

1.2

0.35

0.17

nmol/l

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

323

2826

1.15

1.63

2.9

3.2

0.75

0.82

nmol/l

2.61

256

2184

(3027944) Amphetamines [Presence] in Urine

142

1157

1.23

1.63

1.4

1.5

—

(3000764) Benzodiazepines [Presence] in Urine

145

1186

1.23

1.61

1.4

1.5

—

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

3.57

1.61

1.4

1.8

2.52

1.61

nmol/l

—

(3033799) Differential panel - Peritoneal fluid

414

0.63

1.60

1.7

1.8

—

(3028300) Cannabinoids [Presence] in Urine

146

1196

1.22

1.60

1.4

1.5

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

486

0.66

1.59

1.5

2.0

855.35

3759.29

e6/l

0.84

327

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

2.06

1.59

1.2

—

(40768441) Liver Pathology biopsy report

859

0.74

1.59

1.4

1.3

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

167

1.62

1.57

1.8

1.5

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

105

831

1.27

1.57

1.1

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

456

1.36

1.56

2.4

2.5

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

187

1575

1.19

1.55

6.4

6.3

11.95

12.19

mg/l

0.30

174

1429

(3017704) Immunofixation for Urine

709

1.29

1.55

1.7

—

(3020491) Glucose [Moles/volume] in Blood

780

1.27

1.54

1.8

2.0

6.70

7.07

mmol/l

0.78

530

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

150

1238

1.21

1.54

1.3

1.2

7.59

7.76

mmol/l

0.25

123

1057

(3026250) Tacrolimus [Mass/volume] in Blood

364

1.40

1.54

34.5

32.0

6.68

7.15

ug/l

1.05

329

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

185

1558

1.19

1.54

1.2

290.23

292.74

u/ml

0.04

120

952

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

114

914

1.25

1.54

1.4

0.21

0.24

nmol/l

0.46

608

(3001964) Herpes simplex virus Ag [Presence] in Specimen

298

1.44

1.52

1.7

1.4

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

290

1.45

1.52

1.2

274.24

328.19

pmol/l

0.69

204

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

282

1.46

1.51

1.1

1.2

94.78

85.10

0.51

136

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

563

1.32

1.50

1.3

1.6

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

291

1.44

1.49

1.1

1.2

113.00

103.76

1.23

263

(3010144) Erythrocytes [#/volume] in Synovial fluid

144

1190

1.21

1.48

1.4

92906.53

150338.64

e6/l

0.45

827

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

186

1.56

1.47

1.1

1.2

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

198

1686

1.18

1.46

1.2

—

(3034770) Mitochondria Ab [Titer] in Serum

340

3013

1.13

1.45

1.1

1.2

1070.00

804.17

titre

—

103

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

317

2797

1.14

1.45

1.4

1.5

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

285

1.44

1.1

99.11

84.77

1.41

132

(3015183) Erythrocyte sedimentation rate

369

1.38

1.44

1.3

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

214

1837

1.17

1.44

1.5

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

214

1837

1.17

1.44

1.5

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

156

1.60

1.43

1.1

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

119

971

1.23

1.40

2.8

3.3

13.31

0.01

119

958

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

136

0.44

1.39

1.7

1.2

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

221

1908

1.16

1.39

1.2

1.3

31.61

41.58

u/l

0.94

188

1648

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

2.41

1.39

2.7

2.1

4.11

2.71

mg/l

—

(3032868) Hemoglobin electrophoresis panel in Blood

2.00

1.37

1.7

1.5

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

1.80

1.36

1.1

1.0

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

474

4302

1.11

1.35

2.9

3.4

35.90

47.63

mg/l

1.80

374

3487

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

755

7001

1.08

1.35

1.6

1.5

—

(3012501) Base excess in Blood by calculation

314

2788

1.13

1.33

3.1

4.0

2.58

2.67

mmol/l

0.27

228

1948

(3005988) Vibrio sp identified in Specimen by Organism specific culture

190

1629

1.17

1.32

1.4

—

(3013290) Carbon dioxide [Partial pressure] in Blood

314

2790

1.13

1.32

3.1

4.0

5.03

5.01

kpa

0.19

306

2721

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

170

1445

1.18

1.32

3.1

3.4

5.53

10.45

nmol/l

0.67

165

1408

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

208

1797

1.16

1.31

1.4

—

21.28

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

118

1428

0.82

1.30

4.1

4.8

329.53

363.21

umol/l

1.83

1217

(3007566) Smooth muscle Ab [Titer] in Serum

337

3011

1.12

1.30

1.2

105.36

176.29

titre

0.74

256

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

156

1319

1.18

1.29

1.1

1.0

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

189

1626

1.16

1.27

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

189

1626

1.16

1.27

1.4

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

2.00

1.27

1.0

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.72

1.26

1.6

—

(3023410) Appearance of Cerebral spinal fluid

115

947

1.22

1.26

1.3

1.4

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

473

4311

1.10

1.26

2.8

3.4

55.31

66.67

mg/l

0.32

371

3499

(21494434) Karyotype in Bone marrow

131

1093

1.20

1.26

1.2

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

319

1.38

1.26

2.0

2.7

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

325

2906

1.12

1.24

2.0

2.2

76.51

91.42

ug/min

0.42

169

1654

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

1.74

1.24

1.3

1.1

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

1080

0.80

1.24

2.6

2.2

3.73

2.31

u/field

0.72

414

(3027315) Oxygen [Partial pressure] in Blood

315

2814

1.12

1.23

3.1

4.1

8.58

8.51

kpa

0.32

307

2744

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

119

987

1.21

1.23

1.4

1.6

22.91

24.09

u/ml

0.10

206

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.91

1.22

1.0

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

147

1.57

1.22

1.2

1.1

—

(3006270) Folate [Moles/volume] in Blood

124

1033

1.20

1.22

1.1

1.2

343.16

338.80

nmol/l

0.08

839

(3037756) Immunofixation for Serum or Plasma

321

2873

1.12

1.22

1.6

1.7

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

2.04

1.21

1.2

—

(3029075) Extractable nuclear Ab panel - Serum

296

1.39

1.21

1.0

1.1

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

196

1.48

1.21

1.1

1.2

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

110

907

1.21

1.3

1.5

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

185

1597

1.16

1.21

1.4

108.39

121.59

u/ml

1.29

377

(4146454) Self-monitoring of blood glucose

171

1468

1.17

1.20

2.7

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

314

1.37

1.19

1.4

2.7

155.32

196.17

2.88

296

(3009677) Dengue virus Ab [Presence] in Serum

2.31

1.18

1.0

1.1

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

810

1.22

1.18

1.3

2.33

2.21

mmol/l

0.26

758

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

117

1.62

1.17

1.2

1.1

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

189

1639

1.16

1.17

1.4

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

428

0.70

1.16

1.4

1.9

64043.42

7059.84

e6/l

0.51

230

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

351

1.34

1.14

2.0

1.7

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

124

1041

1.19

1.14

1.3

1.5

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

249

1.41

1.14

1.3

1.1

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

421

1.31

1.14

2.3

2.1

51.77

52.33

umol/l

0.04

348

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

168

1448

1.16

1.14

1.1

69.22

729.61

iu/ml

0.84

297

(3044927) Protein electrophoresis panel - Urine

156

1337

1.17

1.13

1.2

—

(3019977) pH of Arterial blood

706

1.23

1.13

2.8

2.7

7.41

7.42

0.40

282

(43055442) Apixaban [Mass/volume] in Serum or Plasma

200

1.45

1.11

1.7

1.5

103.69

115.96

ug/l

0.31

165

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

582

1.26

1.11

1.1

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

232

2050

1.13

1.11

1.4

—

(3006576) Bicarbonate [Moles/volume] in Blood

388

1.32

1.11

7.6

6.3

25.65

25.14

mmol/l

0.35

350

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

104

862

1.21

1.11

1.5

1.4

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

485

1.28

1.10

2.1

1.9

51.34

55.72

ug/l

0.33

470

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

548

1.26

1.09

1.1

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

2.38

1.09

1.0

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

557

1.26

1.09

1.3

1.66

1.59

g/l

1.43

557

(3024522) Salmonella sp identified in Specimen by Organism specific culture

189

1650

1.15

1.09

1.4

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

456

4186

1.09

1.08

2.8

3.3

1.37

2.90

ratio

1.96

308

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

101

837

1.21

1.08

1.2

1.3

52.86

62.71

titre

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

491

0.73

1.08

1.3

1.4

—

(3036489) Thrombin time

438

4016

1.09

1.07

1.7

1.9

21.94

21.72

0.19

386

3551

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

192

1681

1.14

1.07

1.4

—

(3050129) First trimester maternal screen panel - Serum or Plasma

350

0.69

1.06

1.4

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

301

2711

1.11

1.06

1.5

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

236

1.40

1.06

1.1

—

(3020874) Milk IgE Ab [Units/volume] in Serum

400

1.30

1.06

1.0

0.33

0.74

u/ml

1.22

135

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

506

1.27

1.05

1.2

1.1

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

560

1.25

1.05

2.5

2.3

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

265

2373

1.12

1.04

1.3

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

714

1.22

1.04

1.1

19.81

26.50

u/l

0.87

643

(3028707) Methadone [Presence] in Urine by Screen method

570

1.25

1.03

1.4

1.7

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

535

1.25

1.02

1.2

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

634

1.23

1.02

1.9

2.4

0.22

0.24

e9/l

0.34

556

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

122

1.56

1.02

1.6

1.5

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

103

862

1.20

1.01

1.3

873.75

380.42

titre

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

287

2587

1.11

1.01

3.7

3.6

25.04

27.28

mg/l

0.43

167

1624

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

123

1.55

0.99

5.4

5.9

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

431

1.28

0.99

1.5

1.3

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

133

0.53

0.98

1.0

1.1

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

476

1.26

0.98

1.1

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

167

1459

1.15

0.98

1.1

1.47

1.54

g/l

1.15

145

1321

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

1.67

0.97

1.1

1.2

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

101

848

1.19

0.97

1.5

1.4

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

331

0.69

0.97

1.2

1.5

16.82

13.71

g/l

0.80

259

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

612

1.23

0.96

1.1

289.67

282.96

mg/l

0.08

531

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

1.85

0.96

2.7

4.2

—

(3003721) Smooth muscle Ab [Units/volume] in Serum

1.85

0.96

1.2

—

1.15

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

576

1.23

0.96

1.2

1.1

—

(3020891) Body temperature

532

4948

1.08

0.96

4.8

4.5

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

451

1.26

0.96

1.2

1.1

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

389

1.29

0.96

1.9

1040.86

62136.18

u/ml

—

(3048879) Bone marrow aspiration report

389

1.29

0.96

1.3

1.7

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

102

859

1.19

0.95

1.8

1.6

1184.00

1675.56

titre

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

713

1.21

0.95

1.1

71.61

85.32

u/l

1.54

639

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

443

1.27

0.94

1.1

1156.50

809.35

ng/l

0.18

111

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

524

0.76

0.94

1.2

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

114

971

1.18

0.94

1.4

1.3

1.35

1.46

nmol/l

0.52

108

873

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

184

1624

1.13

0.94

2.5

2.3

545.09

2061.55

u/ml

1.15

104

(3010421) pH of Blood

353

3230

1.10

0.94

3.1

4.0

7.42

0.40

328

2938

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

515

1.24

0.94

1.6

2.0

107.41

96.33

1.57

481

(3050794) Legionella sp Ab [Presence] in Serum

1.61

0.93

1.0

1.2

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

236

2116

1.12

0.93

2.0

1.5

0.83

0.82

nmol/l

0.10

198

1755

(3017937) Magnesium [Moles/time] in 24 hour Urine

2.22

0.93

1.0

1.3

—

(4035726) Immunohistochemistry procedure

1124

11782

0.95

0.93

1.4

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

606

1.22

0.93

1.4

1.5

1.73

3.50

0.91

131

(3024869) Neuronal Ab [Presence] in Serum

217

1.38

0.93

1.1

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

1.73

0.92

1.1

1.4

430.33

321.87

umol/24h

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

204

1816

1.13

0.91

1.4

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

477

4429

1.08

0.91

1.6

1.5

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

126

1.51

0.91

1.2

1.5

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

104

884

1.18

0.89

1.1

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

130

1126

1.16

0.88

1.5

1.7

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

134

1164

1.15

0.88

1.5

28.44

30.51

0.24

698

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

229

2059

1.11

0.88

1.5

1.6

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

129

0.54

0.87

2.3

2.7

1.21

0.98

mg/l

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

150

1316

1.14

0.86

1.5

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

378

1.27

0.86

1.0

1.14

0.48

u/ml

—

(3036603) Volume of Urine

814

1.18

0.86

1.5

2187.86

1802.56

0.81

787

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

178

1.41

0.85

1.2

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

100

851

1.18

0.85

1.2

165.00

161.96

titre

0.01

153

(3036048) Francisella tularensis Ab [Titer] in Serum

221

1.36

0.85

1.2

—

982.50

—

(3044007) Cell count panel - Peritoneal fluid

367

0.74

0.84

1.6

1.9

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

186

1659

1.12

0.83

1.0

1.1

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

120

1040

1.16

0.82

1.9

2.2

—

0.39

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

0.79

0.0

1.0

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

164

1458

1.13

0.79

1.1

1.2

4.14

4.23

u/ml

0.02

466

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

209

1886

1.11

0.78

1.2

1.4

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

148

1.42

0.77

1.2

1.5

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.50

0.77

1.2

1.1

—

(3039443) Prostate specific Ag panel - Serum or Plasma

136

1197

1.14

0.77

1.8

1.7

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

198

1785

1.11

0.76

1.3

1.4

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

1.70

0.75

1.1

1.2

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

1.70

0.75

1.1

1.0

—

(3030313) Adrenal Ab [Titer] in Serum

1.70

0.75

1.0

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

780

1.17

0.74

1.1

1.2

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

1.67

0.74

1.4

—

(3022689) Creatine [Moles/volume] in Urine

351

1.25

0.74

1.6

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

177

1589

1.12

0.74

1.1

—

(3051593) INR in Capillary blood by Coagulation assay

633

1.19

0.74

8.0

10.6

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

352

1.25

0.72

3.8

2.7

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

352

1.25

0.72

3.8

2.7

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

388

1.24

0.72

1.3

1.4

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

607

1.19

0.72

1.4

1.3

1.03

1.21

nmol/l

1.06

469

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

239

2614

0.91

0.72

3.3

3.6

27.24

41.32

u/ml

2.13

229

2535

(3032352) Blasts [#/volume] in Cerebral spinal fluid

1.52

0.72

1.4

1.6

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

288

0.73

0.72

1.5

1.4

28.73

27.32

g/l

0.12

231

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

136

1205

1.13

0.71

1.4

1.6

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

687

0.83

0.71

1.8

1.9

2.08

2.20

u/field

0.05

467

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.75

0.71

1.1

222.29

270.60

nmol/l

—

(3036071) Salmonella sp Ab [Titer] in Serum

264

1.29

0.71

1.2

1.1

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

134

1.42

0.71

1.5

1.6

—

(3023183) Ammonium ion [Moles/volume] in Plasma

217

2381

0.91

0.70

2.4

2.5

33.28

33.52

umol/l

0.04

188

2105

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

388

0.77

0.70

2.0

1.9

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

377

3516

1.07

0.70

1.5

1.6

—

(3020876) Protein [Mass/time] in 24 hour Urine

151

1349

1.12

0.69

2.0

2.5

1.11

1.16

g/24h

0.06

629

(3032057) Clostridioides difficile [Presence] in Stool

283

1.27

0.69

1.8

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

118

1039

1.14

0.69

2.2

1.8

1.20

3.20

titre

—

(3000285) Sodium [Moles/volume] in Blood

181

0.66

0.69

1.5

1.1

—

(3012565) Volume of 24 hour Urine

592

1.18

0.68

1.6

2.3

1826.70

1832.60

0.02

512

(3027231) Wheat IgE Ab [Units/volume] in Serum

135

1.41

0.68

1.0

0.72

0.96

u/ml

0.19

103

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

1.85

0.68

1.0

1.1

1.60

1.28

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

248

1.29

0.68

1.2

1.62

1.68

mmol/l

0.17

158

(3045788) Cell count panel - Pleural fluid

135

1200

1.13

0.68

1.4

1.5

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

455

1.21

0.68

1.1

1.07

1.09

u/l

0.20

222

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

105

918

1.14

0.68

1.2

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

639

1.17

0.68

1.1

40.43

43.59

mg/l

0.23

531

(3008536) Aspergillus sp Ab [Presence] in Serum

231

1.30

0.67

1.9

1.8

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

170

1.35

0.67

1.2

39.13

597.59

ng/l

0.69

122

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

240

1.29

0.67

1.1

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

484

1.20

0.66

4.6

3.8

44.43

582.28

u/ml

—

(3041672) Baker's yeast Ab [Presence] in Serum

1.79

0.66

1.0

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

179

0.67

0.66

1.0

1.2

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

137

1.39

0.64

2.1

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

233

1.29

0.64

1.0

1.1

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

201

0.70

0.64

1.2

1.5

—

(37021550) Renin [Units/volume] in Plasma --upright

260

1.27

0.63

1.3

1.2

69.83

74.78

mu/l

0.06

181

(3034274) Bile acid [Moles/volume] in Serum --fasting

496

1.19

0.63

1.6

1.4

12.77

11.51

umol/l

0.08

359

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

533

1.18

0.63

1.0

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

174

1580

1.10

0.62

1.3

1.4

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

1.55

0.62

1.0

1.1

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

1.55

0.62

1.0

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

279

1.26

0.62

1.1

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

702

1.15

0.61

1.6

84.94

83.12

umol/l

0.18

702

(3017354) Segmented neutrophils/100 leukocytes in Blood

141

1268

1.11

0.61

3.7

3.4

60.28

56.44

1.26

111

1063

(3028433) Virus identified in Specimen by Culture

352

1.22

0.61

1.1

1.2

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

156

1.35

0.60

1.3

1.1

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

156

1.35

0.60

1.2

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

280

1.25

0.60

1.2

1.1

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

0.60

0.0

1.0

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

107

948

1.13

0.59

1.5

1.6

1165.47

1314.23

u/l

0.08

353

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

109

968

1.13

0.59

1.1

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

210

1.29

0.58

1.1

1.3

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

310

0.77

0.58

1.4

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

175

1.31

0.58

1.0

1.1

6.99

9.79

u/ml

0.34

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

282

1.24

0.57

1.1

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

800

1.14

0.57

2.3

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

365

0.79

0.57

1.1

1544.45

1588.91

miu/ml

0.08

365

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

539

1.17

0.57

1.1

1.04

1.07

ratio

0.72

189

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

132

1.36

0.57

2.2

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

310

1.23

0.56

1.6

9.66

9.25

ug/l

0.37

310

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

292

1.23

0.56

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

283

1.24

0.56

1.1

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

1.43

0.56

1.1

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

230

2129

1.08

0.56

5.2

4.9

298.43

1328.80

iu/ml

1.49

338

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

269

2886

0.93

0.56

2.8

3.3

564.04

568.76

u/ml

0.00

231

2629

(3005011) Chlamydia sp Ab [Titer] in Serum

124

1.37

0.55

1.8

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

157

1430

1.10

0.55

1.2

2.98

4.23

u/ml

1.54

601

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

832

1.13

0.54

1.1

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

738

1.14

0.54

1.2

1.3

0.26

1.40

u/ml

3.54

431

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

273

0.77

0.54

2.2

1.8

1.22

2.33

ug/l

3.10

158

(3016273) Islet cell 512 Ab [Units/volume] in Serum

1.58

0.54

1.0

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

312

1.22

0.54

1.2

1.1

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

1.45

0.53

1.0

1.1

—

(3035880) pH of Pleural fluid

722

1.14

0.52

1.2

1.3

—

(40768793) Breast Pathology biopsy report

307

3268

0.94

0.52

1.3

—

(3010375) cycloSPORINE [Mass/volume] in Blood

424

1.18

0.52

29.9

27.3

125.98

109.33

ug/l

0.75

358

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

639

1.14

0.51

1.5

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

639

1.14

0.51

1.5

1.4

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

214

0.75

0.51

1.1

1.7

1.18

1.19

mmol/l

0.19

208

(3024666) Lithium [Moles/volume] in Serum or Plasma

379

1.19

0.50

11.9

11.8

0.60

0.64

mmol/l

0.58

342

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

215

1.26

0.50

1.3

1.6

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

144

1.32

0.50

4.8

4.6

28.69

44.90

ug/min

1.36

120

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

270

1.22

0.49

1.1

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

173

1594

1.09

0.49

1.5

—

(3036670) Protein [Mass/volume] in Synovial fluid

408

1.18

0.49

1.2

41.30

39.30

g/l

0.36

218

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

156

1432

1.09

0.48

1.1

—

(40760888) Immunoglobulin light chains.free panel - Serum

343

3243

1.06

0.48

2.9

3.5

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

1.52

0.48

1.0

1.4

—

(3017509) Phencyclidine [Presence] in Urine

1.52

0.48

1.1

1.3

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

1.40

0.48

1.1

—

(3034988) Calcium [Moles/volume] in Capillary blood

234

0.77

0.48

1.3

1.7

1.18

mmol/l

0.01

224

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

119

1.34

0.48

1.2

1.1

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

281

1.21

0.47

1.4

1.2

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

889

0.89

0.47

1.1

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

111

1.35

0.46

1.1

—

(3036782) Glucose [Moles/volume] in Pleural fluid

130

1187

1.10

0.46

1.2

1.3

6.47

6.36

mmol/l

0.19

119

1088

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

302

1.19

0.44

1.1

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

104

943

1.10

0.43

1.2

1.3

11.26

12.93

u/l

0.52

859

(3008757) Leukocyte morphology finding [Identifier] in Blood

146

1346

1.09

0.43

3.5

3.8

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

202

1.24

0.43

1.0

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

312

2955

1.06

0.43

2.1

2.4

183.78

201.39

3.15

289

2798

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

166

1.27

0.43

2.1

2.8

0.81

0.66

u/field

0.21

166

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

745

0.89

0.42

2.0

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.38

0.42

1.2

1.1

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

294

0.82

0.41

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

294

0.82

0.41

1.4

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

286

1.19

0.41

1.1

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

1.36

0.41

1.1

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

107

976

1.10

0.41

2.3

2.2

—

(3021855) Mononuclear cells [#/volume] in Cerebral spinal fluid

0.00

0.40

0.0

1.2

—

60.64

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

305

1.18

0.40

5.8

5.5

68.07

70.90

0.22

231

(40768806) Pleura Pathology biopsy report

127

1379

0.92

0.40

1.5

1.6

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

293

0.82

0.40

1.3

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

293

0.82

0.40

1.3

1.4

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.40

0.0

2.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.40

0.0

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.40

0.0

2.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.40

0.0

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.40

0.0

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.40

0.0

2.0

—

(46235168) Fasting glucose [Moles/volume] in Blood

106

1.32

0.39

1.5

3.7

6.46

7.48

mmol/l

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

106

1.32

0.39

1.0

1.1

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

316

1.17

0.38

1.3

1.4

24.97

21.56

0.28

264

(3042517) Benzodiazepines panel - Urine

1.39

0.38

1.2

1.6

—

(40768795) Lymph node Pathology biopsy report

122

1322

0.92

0.38

1.2

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

685

0.89

0.38

1.4

1.5

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

695

0.89

0.37

1.4

1.5

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

147

0.75

0.37

1.3

1.4

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

676

1.11

0.37

1.9

2.3

493.82

503.20

e6/l

0.07

567

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

112

0.71

0.37

1.0

—

(3009871) Measles virus Ab [Titer] in Serum

290

1.17

0.36

1.6

1.7

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

393

1.15

0.36

1.0

1.1

93.47

96.85

0.49

294

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

263

1.18

0.35

1.2

1.1

—

(21494890) Protein electrophoresis panel - 24 hour Urine

146

1361

1.07

0.35

1.7

2.0

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.62

0.35

1.0

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

130

1207

1.08

0.35

1.3

366.89

453.36

u/l

0.44

123

1136

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

108

1.30

0.35

1.2

1.3

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

117

1.28

0.35

1.8

2.4

—

(3042631) Mycobacterium sp identified in Specimen

187

1760

1.06

0.35

2.5

2.6

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

232

2198

1.06

0.35

1.2

1.3

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

126

0.71

0.35

1.1

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1.34

0.34

1.2

1.1

—

11.38

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

882

1.09

0.34

1.5

5.43

7.19

u/l

0.75

709

(3043238) Trisomy 21 risk [Likelihood] in Fetus

254

0.83

0.33

1.3

1.4

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

209

1.20

0.33

2.5

2.8

8.14

7.33

mg/l

0.20

168

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

274

1.17

0.33

1.2

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

145

1356

1.07

0.33

1.1

121.41

120.75

0.09

127

1197

(3013166) Neutrophils/100 leukocytes in Synovial fluid

388

1.13

0.32

1.7

1.4

58.36

55.50

0.19

335

(3015076) Soybean IgE Ab [Units/volume] in Serum

313

1.15

0.32

1.1

1.0

0.40

0.26

u/ml

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

111

1031

1.08

0.31

3.9

5.1

271.91

145.03

u/ml

0.40

303

(3044242) Glucose [Moles/volume] in Arterial blood

622

0.90

0.31

1.7

2.1

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

305

1.15

0.30

1.1

1.2

—

(3018133) Calcium [Moles/volume] in Urine

147

1.22

0.30

1.3

1.6

2.02

2.72

mmol/l

1.27

127

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

476

1.11

0.30

1.6

1.5

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

106

985

1.08

0.30

1.3

1.5

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

860

0.92

0.30

1.3

1.2

79.12

82.62

u/l

0.14

748

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

120

1.25

0.30

5.9

4.7

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

401

1.12

0.29

2.7

3.1

30.38

28.42

umol/l

0.57

295

(40758292) HTLV I+II Ab panel - Serum

148

1.22

0.29

1.4

—

(3047189) Immunofixation for 24 hour Urine

597

0.90

0.28

1.6

1.7

—

(3023199) Leukocytes [#/volume] in Pleural fluid

165

1562

1.06

0.28

1.4

1.5

1824.67

2718.32

e6/l

0.94

110

1116

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

248

0.85

0.28

1.1

3.5

55.89

111.51

ng/l

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

470

1.11

0.27

1.2

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

451

1.11

0.27

1.5

1.8

92.38

114.27

umol/l

0.38

243

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.23

0.27

1.0

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

196

1.17

0.27

1.3

1.2

1.28

1.56

mmol/l

0.10

134

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

353

0.88

0.26

1.3

534.60

318.96

ug/l

0.19

191

(3018405) Lactate [Moles/volume] in Arterial blood

449

4354

1.03

0.26

4.3

3.9

1.29

1.37

mmol/l

0.88

442

4279

(40758358) Immune stain study

0.69

0.26

1.0

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

0.69

0.26

1.0

1.2

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

842

0.93

0.26

1.3

1.2

21.20

22.11

u/l

0.06

715

(3036525) Urea [Moles/time] in 24 hour Urine

0.67

0.25

1.8

2.9

—

(3014891) Appearance of Pleural fluid

170

0.82

0.25

1.1

1.2

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

570

0.91

0.24

2.9

2.8

41.29

37.76

0.71

349

(3019174) dRVVT (LA screen)

0.74

0.24

1.3

1.2

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

244

0.86

0.24

1.4

1.3

—

(37019676) Renin [Units/volume] in Plasma --supine

1.32

0.23

1.0

1.1

33.00

47.68

mu/l

—

(3005033) Fetal Nuchal fold Thickness US

243

0.86

0.23

1.3

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

211

0.85

0.23

1.2

—

(3002619) Bacteria identified in Specimen by Culture

228

1.14

0.22

1.0

1.3

—

(3004775) Volume in Urine collected for unspecified duration

1000

0.94

0.22

2.0

2.2

639.73

639.55

0.00

659

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

948

0.94

0.22

1.2

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

391

1.10

0.21

1.0

1.1

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

207

2153

0.96

0.21

1.4

1.5

—

(3024932) HLA-DR beta [Type]

267

1.12

0.21

1.1

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

147

1540

0.95

0.21

2.1

2.3

1475.10

1059.91

u/ml

0.12

147

1525

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

0.21

0.0

1.1

—

(3040151) Glucose [Moles/volume] in Capillary blood

146

1393

1.05

0.21

4.5

10.4

7.04

7.49

mmol/l

1.25

119

1153

(40768446) Kidney Pathology biopsy report

363

1.10

0.21

1.8

1.6

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

344

1.10

0.21

1.1

—

(3020393) Adenovirus Ag [Presence] in Stool

105

0.76

0.21

1.1

1.0

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

332

3223

1.03

0.21

1.3

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

314

0.89

0.20

1.1

2.1

1.25

6.84

ug/l

1.46

164

(40761995) Spermatozoa Progressive [#/volume] in Semen

0.00

0.20

0.0

2.8

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

0.00

0.20

0.0

5.6

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.20

0.0

1.8

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

1.25

0.20

1.0

0.01

0.26

u/ml

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

127

1.18

0.19

1.1

1.0

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

281

0.89

0.19

1.4

1.2

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

375

1.09

0.19

1.3

1.6

2.15

2.00

umol/l

0.56

349

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

173

1663

1.04

0.19

1.5

1.4

—

(3001729) Color of Synovial fluid

122

0.82

0.19

2.4

1.6

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

395

1.09

0.18

1.1

123.55

179.63

iu/ml

1.51

388

(3003434) Protein [Mass/volume] in Pleural fluid

183

1763

1.04

0.18

1.4

1.5

31.40

32.76

g/l

0.85

166

1573

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

632

0.93

0.18

1.1

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

279

0.90

0.17

2.5

2.3

6.82

7.70

mmol/l

1.21

170

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

300

1.10

0.17

1.2

1.3

2.00

2.96

umol/l

1.70

273

(40762814) Titanium [Mass/volume] in Blood

258

0.89

0.17

2.2

2.48

3.74

ug/l

—

(3036180) Methadone [Presence] in Urine

195

1.13

0.17

1.1

1.3

—

(40765089) Chromosome analysis panel - Blood by G-banded

1.13

0.17

1.0

—

(3018834) Bilirubin.total [Presence] in Urine by Test strip

1.13

0.17

3.6

—

0.00

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

884

1.05

0.17

1.0

304.35

334.19

ng/l

0.44

598

(3044416) Complement C4 [Mass/volume] in Pleural fluid

0.74

0.17

1.2

1.1

0.07

g/l

—

(3034426) Prothrombin time (PT)

330

1.09

0.16

1.1

1.2

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

629

0.94

0.16

1.1

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

174

1680

1.04

0.16

1.3

1.2

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

120

1.17

0.16

3.5

2.4

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

782

0.95

0.16

1.3

1.4

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

1.13

0.16

2.9

1.9

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

154

1485

1.04

0.16

1.2

60.11

61.49

u/l

0.11

138

1326

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

111

1.17

0.15

1.0

1.1

47.20

14.26

iu/ml

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

492

4828

1.02

0.15

3.0

3.4

6109.51

1403.28

u/ml

0.41

408

4093

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

506

1.07

0.15

1.4

2.0

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

0.78

0.15

1.0

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

131

1260

1.04

0.15

1.3

1.2

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

216

1.11

0.15

1.6

2.9

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

0.75

0.15

1.2

1.0

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.75

0.15

1.0

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.14

0.15

2.0

2.4

—

(3024471) HLA-A [Type]

274

1.10

0.15

1.0

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

152

1574

0.97

0.15

1.3

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

741

1.05

0.15

1.7

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

536

1.06

0.15

1.1

1.2

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

1.13

0.15

1.0

—

(4212803) Bone marrow aspirate examination

121

1.16

0.15

1.1

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

0.79

0.14

1.1

1.2

—

(3003694) ABO and Rh group [Type] in Blood

2863

28449

1.01

0.14

1.3

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

347

0.92

0.14

1.3

1.2

—

(3026470) Cobalt [Mass/volume] in Blood

851

1.05

0.14

1.9

2.0

3.47

3.40

ug/l

0.04

779

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

636

1.05

0.13

2.1

116.60

151.45

ug/min

—

144

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

122

1.15

0.13

1.1

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

189

1.11

0.13

1.1

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

502

5104

0.98

0.13

2.1

1.9

3.06

2.20

ug/l

0.40

439

4471

(3016750) Collection duration of Urine

715

0.95

0.13

2.0

485.45

494.95

min

0.37

520

(3022493) Free Hemoglobin [Mass/volume] in Plasma

459

0.94

0.13

7.3

4.0

5836.94

512.72

mg/l

0.44

327

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

892

1.04

0.13

1.0

41.15

46.51

ng/l

0.47

593

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

113

1.15

0.13

1.3

1.9

16.50

18.72

umol/l

0.42

113

(3043410) Blood group antigens tested for on Red Blood Cells

304

0.92

0.13

1.5

1.8

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

238

1.09

0.13

1.4

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

113

1090

1.04

0.12

1.4

1.3

33.00

39.19

u/l

1.13

885

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

1.18

0.12

1.3

1.89

0.86

ml/s/173m2

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

600

0.95

0.12

2.1

3.2

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

269

1.08

0.11

2.0

2.2

—

(21494814) CD8 cells/100 lymphocytes in Specimen

445

0.94

0.11

2.0

—

(3028717) Thiamine [Mass/volume] in Blood

105

1.14

0.11

1.1

—

(3052592) Norovirus Ag [Presence] in Stool

250

1.08

0.11

1.5

1.3

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

799

1.04

0.10

1.0

1.1

288.60

293.86

mg/l

0.28

714

(3001186) Copper [Moles/volume] in Serum or Plasma

229

0.92

0.10

1.0

1.2

15.95

16.99

umol/l

0.65

205

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

173

1.10

0.10

1.3

95.33

58.36

u/l

0.21

127

(3045142) Bone marrow Pathology biopsy report

145

1412

1.03

0.10

1.3

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

484

0.95

0.10

1.3

1.4

64.03

64.73

0.04

399

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

890

1.03

0.09

1.0

678.87

701.81

ng/l

0.21

585

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

361

0.94

0.09

1.8

1.5

0.35

0.38

ug/l

0.16

223

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

768

0.96

0.09

1.6

1.7

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

1.06

0.09

1.0

1.2

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

1.06

0.09

1.0

1.4

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

146

1425

1.02

0.09

1.4

66743.10

49477.29

e6/l

0.14

823

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

306

3012

1.02

0.09

1.5

1.6

—

(3051101) Glucose [Moles/volume] in Cord blood

237

0.93

0.09

5.2

6.2

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

498

1.04

0.08

1.4

2.0

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

498

1.04

0.08

1.4

2.0

—

(3029396) Erythrocyte agglutination [Presence] in Blood

0.82

0.08

2.8

2.0

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

637

1.04

0.08

1.3

1.5

—

(3022475) Manganese [Moles/volume] in Blood

1.04

0.08

1.0

1.4

—

(3017569) Oxygen content in Arterial blood

628

1.04

0.07

1.7

2.3

—

(3046861) Legionella sp Ag [Presence] in Urine

0.86

0.07

1.0

1.1

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

167

1639

1.02

0.07

1.1

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

225

1.07

0.07

1.3

1.2

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.86

0.07

1.1

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

0.86

0.07

1.1

8.71

10.44

u/l

—

(3044009) aPTT.lupus sensitive (LA screen)

0.84

0.07

1.3

1.2

—

(3025577) Chromium [Mass/volume] in Blood

827

1.03

0.07

2.0

2.1

2.41

2.35

ug/l

0.07

688

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

118

1.10

0.07

1.0

1.1

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

206

1.07

0.07

1.0

1.45

0.94

u/ml

—

(3026726) Creatinine [Moles/volume] in Specimen

0.86

0.06

1.8

2.4

99.75

452.66

umol/l

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

317

3207

0.99

0.06

1.9

2.0

91.00

91.18

0.05

299

3068

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

581

1.03

0.06

1.3

1.5

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

581

1.03

0.06

1.3

1.5

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

609

0.97

0.06

3.0

3.7

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

299

3023

0.99

0.06

1.4

113.61

195.15

pmol/l

3.73

292

2947

(40768800) Prostate Pathology biopsy report

196

1987

0.99

0.05

1.2

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

106

1039

1.02

0.05

1.3

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

106

1039

1.02

0.05

1.3

1.6

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

106

1039

1.02

0.05

1.1

93.12

94.15

0.18

968

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

106

1039

1.02

0.05

1.3

1.6

—

(3000060) B lymphocytes [#/volume] in Blood

218

1.06

0.05

1.7

1.9

149.09

1010.19

e6/l

1.27

106

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

440

4434

0.99

0.05

2.4

2.9

0.37

0.36

u/ml

0.21

251

2534

(3034092) Cytoplasmic Ig cells/100 cells in Blood

130

0.92

0.04

4.5

9.7

—

(3035933) Granulocytes/100 leukocytes in Blood

199

1.06

0.04

1.5

1.7

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

231

0.95

0.04

1.0

1.1

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

453

0.97

0.04

2.8

2.7

—

(3042733) HLA Ab [Presence] in Serum

259

1.04

0.04

5.3

4.8

—

(40765096) Chromosome analysis panel by Banding

368

1.03

0.04

1.2

1.1

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

644

0.98

0.04

1.3

1.8

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

773

0.98

0.03

5.1

6.3

—

(3004809) Band form neutrophils/100 leukocytes in Blood

209

2073

1.01

0.03

3.7

3.4

1.40

1.61

0.32

175

1829

(3006922) Hepatitis E virus Ab [Presence] in Serum

692

0.98

0.03

1.1

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

168

0.95

0.02

1.3

1.4

46.00

50.33

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

931

0.99

0.02

1.6

1.5

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

102

1009

1.01

0.02

1.6

1.9

3.26

4.19

mg/l

3.13

954

(3023511) Choriogonadotropin [Units/volume] in Urine

451

1.02

0.02

1.2

1.3

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

232

1.03

0.02

1.1

—

(40757373) Influenza virus identified in Isolate

242

1.03

0.02

2.1

1.4

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

127

0.94

0.01

1.0

1.1

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1458

14563

1.00

0.01

3.5

4.1

17.90

20.63

ug/l

0.21

1163

11940

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

647

0.99

0.01

1.3

1.8

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

226

0.97

0.00

3.5

5.4

37.91

53.18

u/l

1.00

220

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

1.04

0.00

1.0

1.6

—

(3013293) Extractable nuclear Ab [Presence] in Serum

184

0.98

0.00

1.5

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

214

0.98

0.00

1.2

1.4

14.62

11.47

0.21

113

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

112

0.98

0.00

1.2

1.1

—

(40758047) Lysozyme [Mass/volume] in Pleural fluid

118

1.02

0.00

1.2

1.1

10.27

9.25

mg/l

0.09

109

(40757494) Bilirubin.total [Moles/volume] in Blood

656

1.01

0.00

2.4

2.1

17.55

29.64

umol/l

—

(3009015) Lactate [Moles/volume] in Synovial fluid

152

0.99

0.00

1.3

1.2

6.89

6.74

mmol/l

—

(3012441) Differential panel - Pleural fluid

134

1345

1.00

0.00

1.4

1.5

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

115

0.96

0.00

1.0

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

312

3118

1.00

0.00

2.1

2.4

3.57

3.63

g/l

0.32

293

2969

(3001893) Eosinophils/100 leukocytes in Pleural fluid

411

1.00

0.00

1.3

1.4

3.05

2.45

0.24

347

(3011412) CD3 cells [#/volume] in Blood

101

1011

1.00

0.00

2.0

2.2

1.18

1.11

e9/l

0.43

919

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

0.94

0.00

1.1

1.0

—

(3007463) Buprenorphine [Presence] in Urine

0.00

-0.00

0.0

3.3

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

0.98

-0.00

1.2

1.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

250

1.00

-0.00

1.1

—

(3001218) Citrate [Mass/time] in 24 hour Urine

0.00

-0.00

0.0

1.7

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3028917) Waxy casts [#/area] in Urine by Computer assisted method

0.00

-0.00

0.0

1.2

—

(3030940) RBC casts [#/area] in Urine by Computer assisted method

0.00

-0.00

0.0

1.2

—

(3009992) Blasts/100 cells in Bone marrow

0.00

-0.00

0.0

2.0

—

13.38

—

(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

-0.00

0.0

1.3

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

735

7350

1.00

-0.00

2.8

4.0

39.49

68.79

u/ml

3.19

709

7080

(3013336) Amino acids [Identifier] in Serum or Plasma

0.00

-0.00

0.0

5.1

—

(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid

0.00

-0.00

0.0

1.1

—

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

0.00

-0.00

0.0

1.6

—

(3029612) Listeria sp Ab [Titer] in Serum

0.00

-0.00

0.0

1.2

—

(3043614) Bacteria identified in Aspirate by Culture

0.00

-0.00

0.0

1.0

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

(3028468) Fragments [Presence] in Blood by Light microscopy

0.00

-0.00

0.0

1.0

—

(40761593) Coagulation factor VIII Ab [Presence] in Platelet poor plasma by Immunoassay

0.00

-0.00

0.0

1.5

—

(3008896) Cortisol [Moles/volume] in Urine

0.00

-0.00

0.0

1.0

—

(3012932) Hazelnut IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

5.40

—

(3008343) Lysozyme [Mass/volume] in Urine

0.00

-0.00

0.0

1.0

—

0.44

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

1.01

-0.00

1.1

1.0

—

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

0.00

-0.00

0.0

1.3

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

160

1.00

-0.00

18.4

11.1

4.74

4.87

mmol/l

0.15

160

(3042628) Porphyrins [Moles/volume] in Urine

0.00

-0.00

0.0

1.0

—

(40760866) Procollagen type III.N-terminal propeptide [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3025566) Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.1

—

Mortality – FinRegistry

↥

Association

Association between endpoint H7_BLEPHAROCHALASIS and mortality.

Females

Parameter	HR [95% CI]	p-value
H7_BLEPHAROCHALASIS	0.789 [0.73, 0.85]	< 0.001
Birth year	0.995 [0.99, 1.0]	0.216

During the follow-up period (1.1.1998 — 31.12.2019), 5529 out of 37804 females with H7_BLEPHAROCHALASIS died.

Males

Parameter	HR [95% CI]	p-value
H7_BLEPHAROCHALASIS	0.903 [0.82, 1.0]	0.04
Birth year	0.987 [0.98, 1.0]	0.005

During the follow-up period (1.1.1998 — 31.12.2019), 3131 out of 15678 males with H7_BLEPHAROCHALASIS died.

Mortality risk

Mortality risk for people of age

years, who have H7_BLEPHAROCHALASIS.

N-year risk	Females	Males
1	0.074%	0.159%
5	0.439%	1.127%
10	1.108%	2.791%
15	2.133%	5.154%
20	3.839%	8.469%

Relationships between endpoints

↥

Index endpoint: H7_BLEPHAROCHALASIS – Blepharochalasis

GWS hits: 17

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Blepharochalasis

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints